Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

W
Waanders F. - HIGH ABSOLUTE RISKS AND PREDICTORS OF VENOUS AND ARTERIAL THROMBOEMBOLIC EVENTS IN PATIENTS WITH NEPHROTIC SYNDROME
Wada H. - ELEVATED D-DIMER LEVELS IN PATIENTS WITH DEEP VEIN THROMBOSIS
  - ADAMTS13 RELATED MARKERS IN PLASMA FROM PATIENTS WITH TTP
Waddington S.N. - HEPATIC TARGETING OF ADENOVIRUS MEDIATED BY COAGULATION FACTOR X
Wadsworth L.D. - MOLECULAR CHARACTERIZATION OF A 4.4MBP DELETION OF THE HUMAN X CHROMOSOME IN A PATIENT WITH HAEMOPHILIA B
Waegemans T. - A MULTICENTRE PROSPECTIVE OPEN-LABEL STUDY ASSESSING PHARMACOKINETICS, CLINICAL EFFICACY AND SAFETY OF A TRIPLE-SECURED FIBRINOGEN CONCENTRATE: FIBRINOGENE T-I
  - A PROSPECTIVE EFFICACY AND SAFETY STUDY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED FACTOR VIII ADMINISTERED BY CONTINUOUS INTRAVENOUS INFUSION IN SEVERE HAEMOPHILIA A PATIENTS UNDERGOING MAJOR SURGICAL PROCEDURES (PERFACT STUDY)
Wagenvoord R.J. - THE EFFECT OF DIRECT THROMBIN INHIBITORS (DTIS) IN CLOTTING PLASMA
Wagner D.D. - PROTHROMBOTIC EFFECTS OF FIBRONECTIN ISOFORMS CONTAINING THE EDA DOMAIN
  - CALDAG-GEFI-DEFICIENCY CAUSES IMPAIRED BETA1, BETA2, AND BETA3 INTEGRIN ACTIVATION IN NEUTROPHILS AND PLATELETS: A MODEL FOR LEUKOCYTE ADHESION DEFICIENCY-III (LAD-III)
  - CHARACTERIZATION OF THE ROLE OF PLATELET ADHESION MOLECULES IN A MURINE MODEL OF PHOTOSENSITIZER-INDUCED STROKE
Wagner D. - PLATELETS AND LEUKOCYTE INTERACTION WITH THE VESSEL WALL
Wagner O. - CIRCULATING P-SELECTIN AND THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM
Wagner D.D. - PEROXIREDOXIN, PRDX1 PLAYS AN IMPORTANT ROLE IN INFLAMMATION AND EARLY ATHEROSCLEROSIS
  - ROLE OF PLASMA FIBRONECTIN IN FIBRINOGEN/VWF-INDEPENDENT THROMBUS FORMATION
  - ABSENCE OF ADAMTS13 ON A VWF DEFICIENT BACKGROUND IS NO LONGER PROTHROMBOTIC IN A MURINE MODEL OF ARTERIAL THROMBOSIS
Wagner-Whyte J. - DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
  - PHARMACOKINETIC/PHARMACODYNAMIC PROFILE OF A NOVEL APTAMER DIRECT THROMBIN INHIBITOR IN CYNOMOLGUS MONKEYS AND YORKSHIRE PIGS FOLLOWING A SINGLE IV BOLUS ADMINISTRATION
Wahi R. - COMPARATIVE STUDY ON THE ANTICOAGULANT EFFECTS OF UNFRACTIONATED AND LOW MOLECULAR WEIGHT HEPARINS, LOWER LOW MOLECULAR WEIGHT HEPARINS AND PENTASACCAHRIDE AS MEASURED BY WHOLE BLOOD ACT, ANTI-XA AND A NEWLY DEVELOPED PROTHROMBINASE INDUCED CLOTTING TIME
  - PREVALENCE OF CROSS-REACTIVE EPITOPES TO BOVINE FACTOR VA LIGHT CHAIN FRAGMENTS IN NORMALS AND END STAGE RENAL DISEASE PATEINTS
  - UPREGULATION OF MYELOPEROXIDASE IN END STAGE RENAL DISEASE AND ITS MODULATION BY HEMODIALYSIS
Wahi M.M. - THE RISK FOR THROMBOEMBOLIC DISEASE IN LUPUS ANTICOAGULANT PATIENTS DUE TO PATHWAYS INVOLVING P-SELECTIN AND CD154
Wahi R. - ANTIINFLAMMATORY EFFECTS OF ARGATROBAN CAN BE DIFFERENTIATED FROM OTHER DIRECT THROMBIN INHIBITORS. EXPERIMENTAL AND CLINICAL OBSERVATIONS
Wahl D. - INFLUENCE OF INJECTION SITE ON PROPHYLACTIC DOSE ENOXAPARIN BIOAVAILABILITY IN OBESE PATIENTS
  - PLATELET ACTIVATION REINFORCES THE PROCOAGULANT PHENOTYPE INDUCED BY MURINE MONOCLONAL ANTI-PHOSPHOLIPID ANTIBODIES
Wahl D.G. - SIGNIFICANCE OF PLASMA SOLUBLE ENDOTHELIAL PROTEIN C RECEPTOR AND TISSUE FACTOR PATHWAY INHIBITOR IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
Wåhlander K. - EFFECT OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 ON GLOMERULAR FILTRATION RATE IN ELDERLY HEALTHY SUBJECTS
  - CPU INHIBITION WITH AZD9684: PROFIBRINOLYTIC EFFECTS IN ACUTE PE PATIENTS
  - IL-1BETA-INDUCED TISSUE-TYPE PLASMINOGEN ACTIVATOR SUPPRESSION IN VASCULAR ENDOTHELIAL CELLS IS MEDIATED BY NF-KAPPAB SIGNALING
  - SAFETY AND TOLERABILITY OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 IN PREVENTION OF STROKE AND OTHER THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH ATRIAL FIBRILLATION (AF)
  - ASSESSMENT OF THE ELECTROPHYSIOLOGICAL EFFECTS OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837, IN SUBJECTS UNDERGOING AN INVASIVE ELECTROPHYSIOLOGICAL PROCEDURE
Wain G. - VENOUS THROMBOEMBOLISM AND GYNAECOLOGICAL ONCOLOGY SURGERY
Wait R. - HEPARIN TREATMENT INCREASES TYROSINE PHOSPHORYLATION OF PROTEINS IN BREAST CANCER CELLS: DIFFERENCES IN THE EFFECT OF LMWH AND UFH
  - PROTEOME OF ENDOTHELIAL CELL-DERIVED PROCOAGULANT MICROPARTICLES
Waitman D.D.A. - PERFORMANCE EVALUATION OF THE COAGUCHEK XS SYSTEM IN ROUTINE PATIENT ANTICOAGULATION MANAGEMENT CLINICS IN ISRAEL
Wakabayashi H. - LEU335 CONTRIBUTES TO THE EFFICIENT PROTEOLYSIS OF FACTOR VIIIA AT ARG336 CATALYZED BY ACTIVATED PROTEIN C
Walberer M. - INDUCTION OF ENDOTHELIAL CELL HYPERPERMEABILITY BY EXTRACELLULAR RNA
Walenga J.M. - DIFFERENCES IN THE OLIGOSACCHARIDE COMPOSITION OF GENERIC VERSIONS OF ENOXAPARIN AND DALTEPARIN
  - INCIDENCE OF ANTI-HEPARIN/PLATELET FACTOR 4 (AHPF4) ANTIBODIES AND HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) IN MEDICAL PATIENTS
  - DEFIBROTIDE AND ITS MOLECULAR FRACTIONS DO NOT CROSS-REACT WITH HIT ANTIBODIES. IMPLICATIONS IN THE MANAGEMENT OF HIT
  - DOWN REGULATION OF THROMBOTIC AND INFLAMMATORY MEDIATORS IN PATIENTS WITH ACUTE CORONARY SYNDROME TREATED WITH CLOPIDOGREL. RELEVANCE TO THE OBSERVED CLINICAL EFFECTS
  - NITRIC OXIDE LEVELS ARE INCREASED FOLLOWING BRACHYTHERAPY COMPARED TO STENTING. IMPLICATIONS IN CORONARY RESTENOTIC COMPLICATIONS
  - POTENTIAL OF THE FACTOR XA INHIBITOR RIVAROXABAN FOR THE ANTICOAGULATION MANAGEMENT OF PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA
  - DIFFERENTIAL EFFECTS OF FXA INHIBITORS AND HEPARINS IN SIMULATED ARTERIAL AND VENOUS THROMBOSIS
  - ANTIINFLAMMATORY EFFECTS OF ARGATROBAN CAN BE DIFFERENTIATED FROM OTHER DIRECT THROMBIN INHIBITORS. EXPERIMENTAL AND CLINICAL OBSERVATIONS
  - UPREGULATION OF MICROPARTICLES IN HEPARIN INDUCED THROMBOCYTOPENIA (HIT) AND IT'S MODULATION BY ARGATROBAN
  - COMPARATIVE STUDY ON THE ANTICOAGULANT EFFECTS OF UNFRACTIONATED AND LOW MOLECULAR WEIGHT HEPARINS, LOWER LOW MOLECULAR WEIGHT HEPARINS AND PENTASACCAHRIDE AS MEASURED BY WHOLE BLOOD ACT, ANTI-XA AND A NEWLY DEVELOPED PROTHROMBINASE INDUCED CLOTTING TIME
  - PLATELET-BOUND PF4 IS TARGETED BY HIT ANTIBODIES IN THE ABSENCE OF HEPARIN
Walenga J. - GENERIC VERSIONS OF BRANDED LOW MOLECULAR WEIGHT HEPARINS CAN BE DIFFERENTIATED IN BIOLOGIC AND PHARMACOLOGIC ASSAYS
Walenga J.M. - ARGATROBAN IS CAPABLE OF PASSING THROUGH THE BLOOD BRAIN BARRIER. POTENTIAL IMPLICATIONS IN THE MANAGEMENT OF THROMBOTIC STROKE
  - EVALUATION OF ALLOSTERIC INHIBITORS OF PAR1 ON PLATELET ACTIVATION
Walenga J. - EVALUATION OF A NEW FUNCTIONAL CLOTTING ASSAY FOR THE MONITORING OF HEPARIN AND HEPARINOID ANTICOAGULANTS BASED ON THROMBIN AND/OR FACTOR XA INHIBITION WITH CLINICAL PATIENT PLASMAS AT THREE UNIVERSITY MEDICAL CENTERS
Walenga J.M. - RECOMBINANT THROMBOMODULIN DOES NOT CROSS REACT WITH ANTI-HEPARIN PLATELET FACTOR 4 ANTIBODIES. POTENTIAL IMPLICATION FOR ANTICOAGULATION OF HEPARIN-INDUCED THROMBOCYTOPENIA PATIENTS
Walfridsson H. - ASSESSMENT OF THE ELECTROPHYSIOLOGICAL EFFECTS OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837, IN SUBJECTS UNDERGOING AN INVASIVE ELECTROPHYSIOLOGICAL PROCEDURE
Walker I.D. - SOURCE AND USE OF REFERENCE RANGES IN HAEMOSTASIS: PRACTICE AMONGST UK NEQAS FOR BLOOD COAGULATION PARTICIPANTS 2005-6
Walker G.F. - DESIGN OF A PLATELET SUBSTITUTE UTILISING HOST FIBRINOGEN TO ENHANCE HAEMOSTASIS
Walker I.R. - EFFICACY OF TEACHING CLINICAL CLERKS AND RESIDENTS ABOUT MANAGEMENT OF BLEEDING AND COAGULATION DISORDERS USING E-LEARNING
Walker K. - ENHANCED TOLEROGENIC PRESENTATION OF FVIII BY ANDROGRAPHOLIDE-TREATED IMMATURE DENDRITIC CELLS
Walker I.D. - DIFFERENCES IN THROMBOPHILIA ASSAY RESULTS BETWEEN COMMERCIAL REFERENCE PLASMAS USING THE SSC/ISTH SECONDARY COAGULATION STANDARD LOT#3 IN UK NEQAS FOR BLOOD COAGULATION PROFICIENCY TESTING EXERCISES
Walker A. - NOVEL PLATELET TRANSMEMBRANE PROTEINS: IDENTIFICATION AND ANALYSIS
Walker I. - THE UK NATIONAL EXTERNAL QUALITY ASSESSMENT SCHEME (UK NEQAS) FOR MOLECULAR GENETIC TESTING IN HAEMOPHILIA
Walker I.D. - IMPLEMENTING AN EXTERNAL QUALITY ASSESSMENT PROGRAMME FOR USERS OF COAGUCHEK XS AND COAGUCHEK XS PLUS FOR MONITORING INRS
Walker M.C. - FACTOR V LEIDEN (FVL) AND PROTHROMBIN GENE VARIANT (PGV) MAY BE ONLY WEAKLY ASSOCIATED WITH PLACENTA MEDIATED PREGNANCY COMPLICATIONS: A LARGE PROSPECTIVE COHORT STUDY
Walker I.D. - THE GOAL STUDY: A PROSPECTIVE EXAMINATION OF THE IMPACT OF FACTOR V LEIDEN AND ABO (H) BLOOD GROUPS ON HAEMORRHAGIC AND THROMBOTIC PREGNANCY OUTCOMES
  - THE SSC/ISTH SECONDARY COAGULATION STANDARD LOT#3 IN UK NEQAS FOR BLOOD COAGULATION PROFICIENCY TESTING EXERCISES: MARKED DIFFERENCES IN FV AND FXI RESULTS BETWEEN COMMERCIAL REFERENCE PLASMAS
  - THE INFLUENCE OF FACTOR V LEIDEN AND ABO(H) BLOOD GROUPS ON HAEMATOLOGY PARAMETERS IN EARLY PREGNANCY
  - VARIABILITY IN ANTICOAGULANT DOSING RECOMMENDATIONS; RESULTS FROM TWO UK NEQAS FOR BLOOD COAGULATION EXERCISES
Walker I. - ANTICARDIOLIPIN ANTIBODIES AND OUTCOME OF PREGNANCY A RETROSPECTIVE 3 YEAR STUDY
Walker I.D. - PREDICTING RISK OF RECURRENT VENOUS THROMBOSIS USING A 5-POINT SCORING SYSTEM INCLUDING FIBRIN D-DIMER
Walker I. - CHALLENGES IN DEFINING TYPE 2M VON WILLEBRAND DISEASE: RESULTS FROM A CANADIAN COHORT STUDY
Walker A. - N-GLYCAN SIALYLATION IS IMPORTANT FOR IN VIVO RECOVERY OF RECOMBINANT FACTOR IX
Walker I.D. - AN EXTERNAL QUALITY ASSESSMENT PROGRAMME FOR PATIENT SELF-TESTING FOR MONITORING INRS- 2 YEARS OF RESULTS
Walker I. - THE CANADIAN RARE INHERITED BLEEDING DISORDERS REGISTRY (RIBDR) OF COAGULATION FACTOR DEFICIENCIES AND PLATELET FUNCTION DISORDERS
Walkowiak B. - DIAMOND PARTICLES OF MICROMETRIC SIZE ARE INTERNALIZED BY ENDOTHELIAL CELLS
Wall U. - CPU INHIBITION WITH AZD9684: PROFIBRINOLYTIC EFFECTS IN ACUTE PE PATIENTS
Wallén H. - MEASUREMENTS OF FIBRINOGEN AND CRP CONCENTRATIONS IN EDTA AND CITRATE PLASMA
Wallen H.N. - INCREASED THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) LEVELS IN EXPERIMENTAL HUMAN ENDOTOXEMIA IS CAUSED BY BOTH INFLAMMATORY RESPONSE AND THROMBIN GENERATION
Wallen H. - DOES ANGIOTENSIN II HAVE PROINFLAMMATORY OR PROTHROMBOTIC EFFECTS?
Wallen N.H. - FIBRIN GEL POROSITY: COMPARISON OF TWO LABORATORY ASSAYS
Wallén H.N. - EFFECT OF CLOPIDOGREL TREATMENT ON STRESS-INDUCED PLATELET ACTIVATION AND MYOCARDIAL ISCHEMIA IN ASPIRIN-TREATED PATIENTS WITH STABLE CORONARY ARTERY DISEASE
Wallen N.H. - FIBRIN GEL POROSITY RELATES TO GLYCOSYLATED HAEMOGLOBIN IN PATIENTS WITH TYPE 1 DIABETES
Wallén H. - COMPARISON OF THREE DIFFERENT TAFI ASSAYS IN PATIENTS WITH ACUTE CORONARY SYNDROME
  - PREANALYTICAL CONDITIONS INFLUENCING FLOW CYTOMETRIC DETERMINATION OF PLATELET-DERIVED MICROPARTICLES (PDMP)
Wallentin L. - GREATER INHIBITION OF PLATELET ACTIVATION AND PLATELET-MONOCYTE COMPLEX FORMATION BY PRASUGREL COMPARED TO CLOPIDOGREL IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
  - GREATER PLATELET P2Y12 INHIBITION BY PRASUGREL COMPARED TO HIGH DOSE CLOPIDOGREL ASSESSED BY VASP PHOSPHORYLATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
Walsh M.T. - ABSENCE OF ADAMTS13 ON A VWF DEFICIENT BACKGROUND IS NO LONGER PROTHROMBOTIC IN A MURINE MODEL OF ARTERIAL THROMBOSIS
Walsh P.N. - MECHANISMS OF FACTOR XIA INHIBITION BY TWO KUNITZ TYPE INHIBITORS, PROTEASE NEXIN 2 KPI DOMAIN AND BASIC PANCREATIC TRYPSIN INHIBITOR (BPTI)
Walsh M.L. - IN VIVO RECOVERY OF RISTOCETIN CO-FACTOR IN PATIENTS WITH VON WILLEBRAND DISEASE UNDERGOING PROCEDURES REQUIRING TREATMENT WITH HAEMATE P
Walsh G.M. - S-NITROSYLATION OF THE PLATELET INTEGRIN ALPHA IIB BETA 3
Walsh M.T. - PROTHROMBOTIC EFFECTS OF FIBRONECTIN ISOFORMS CONTAINING THE EDA DOMAIN
Walsh P.N. - FACTOR XIA RESIDUES TYR143, GLU98, AND LYS192 ARE IMPORTANT FOR SUBSTRATE FACTOR IX (FIX) AND S-2366 CATALYSIS
Waltenberger J.L. - THROMBOXANE B2 IN PATIENTS WITH A FIRST ACUTE MYOCARDIAL INFARCTION: THE INFLUENCE OF TREATMENT WITH ACETYLSALICYLIC ACID
  - THROMBIN GENERATION AND COAGULATION MARKERS IN PATIENTS WITH A FIRST ACUTE MYOCARDIAL INFARCTION
Walter U. - PLATELET PROINFLAMMATORY AND HEMOSTATIC FUNCTIONS IN PATIENTS WITH CYSTIC FIBROSIS
  - ANALYSIS OF THE INTERACTOME IN HUMAN PLATELETS
Walter O. - CLINICAL EFFICACY AND SAFETY OF A NOVEL HIGH-PURITY, DOUBLE VIRUS-INACTIVATED VWF/FVIII-CONCENTRATE IN THE TREATMENT OF VON WILLEBRAND DISEASE AN UPDATE ON THE CLINICAL PROGRAMME
Walter U. - CROSS-TALK OF VWF/GPIB- AND NO/CGMP-INDUCED SIGNALING IN HUMAN PLATELETS
  - HEREDITARY ANGIOEDEMA TYPE III ARE CAUSED BY A GAIN OF FUNCTION MUTATION IN COAGULATION FACTOR XII, WHICH INCREASES VASCULAR PERMEABILITY MEDIATED BY BRADYKININ GENERATION
  - ASSOCIATION OF ADAMDEC1 HAPLOTYPE WITH HIGH FACTOR VIII LEVELS IN VENOUS THROMBOEMBOLISM
Walterova L. - LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Walton J. - DIFFERENCES IN PLATELET RESPONSE TO ADP AND CRP ARE CORRELATED WITH VARIATION IN THE RESTING PLATELET TRANSCRIPTOME
  - INHERENT VARIATION INDONOR PLATELET REACTIVITY CONTRIBUTES TO THE QUALITY OF APHERESIS PLATELETS
  - ANALYSING PLATELET FUNCTION FOR FUNCTIONAL GENOMIC STUDIES
  - PROTEOMIC ANALYSIS OF PLATELET DETERGENT-RESISTANT MEMBRANES FROM HEALTHY HUMAN DONORS WITH "EXTREME-END" RESPONSES TO COLLAGEN-RELATED PEPTIDE AND ADP
  - THE EFFECT OF APHERESIS ON DONORS' PLATELETS
Wanert F. - EX VIVO ANTITHROMBOTIC EFFECTS OF ANTI GPVI FAB FRAGMENT IN NON-HUMAN PRIMATES WITHOUT MODIFICATION OF GPVI EXPRESSION
Wang X. - MOLECULAR MECHANISMS IN TWO CHINESE PATIENTS WITH INHERITED AFIBRINOGENEMIA
Wang H. - MOLECULAR MECHANISMS IN TWO CHINESE PATIENTS WITH INHERITED AFIBRINOGENEMIA
Wang Z. - MOLECULAR MECHANISMS IN TWO CHINESE PATIENTS WITH INHERITED AFIBRINOGENEMIA
Wang X. - 8 NOVEL MUTATIONS IDENTIFIED GLANZMANN THROMBASTHENIA FAMILIES FROM CHINA
Wang H. - 8 NOVEL MUTATIONS IDENTIFIED GLANZMANN THROMBASTHENIA FAMILIES FROM CHINA
Wang Z. - CROSS REACTION OF ANTIBODY AGAINST HELICOBACTER PYLORI UREASE B WITH PLATELET GLYCOPROTEIN IIIA AND ITS SIGNIFICANCE IN THE PATHOGENESIS OF ITP
Wang L. - EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY
Wang Q. - P2RY12 RECEPTOR POLYMORPHISMS (SNPS) IN PATIENTS WITH A HISTORY OF MYOCARDIAL INFARCTION
Wang Y. - IMPAIRED RESPONSIVENESS OF PLATELETS TO EPINEPHRINE IN CHINESE RELATED TO A2A ADRENOCEPTOR POLYMORPHISMS
Wang H. - SIGNAL TRANSDUCTION PATHWAYS OF INTERLEUKIN-6 INDUCING TISSUE FACTOR EXPRESSION IN VASCULAR ENDOTHELIAL CELLS
Wang X. - A NOVEL DELETION MUTATION (C.1254 DEL33BP OR C.1251DEL33BP) IN THE F13A GENE CAUSING SEVERE FACTOR XIII DEFICIENCY
Wang H. - A NOVEL DELETION MUTATION (C.1254 DEL33BP OR C.1251DEL33BP) IN THE F13A GENE CAUSING SEVERE FACTOR XIII DEFICIENCY
Wang X. - GENETIC ANALYSIS OF HEREDITARY PROTEIN S DEFICIENCY IN TWO CHINESE PEDIGREES
Wang H. - GENETIC ANALYSIS OF HEREDITARY PROTEIN S DEFICIENCY IN TWO CHINESE PEDIGREES
Wang L. - SMOOTH MUSCLE-DERIVED TISSUE FACTOR IS CRITICAL FOR ARTERIAL THROMBOSIS AFTER FECL3 INJURY
Wang T. - LOSS OF SEMA4D SIGNALING BETWEEN PLATELETS DESTABILIZES ARTERIAL THROMBI AND REDUCES MYOCARDIAL INFARCT SIZE
Wang H. - ANTIDOTE REVERSAL OF A NOVEL ANTICOAGULANT DECREASES MORTALITY AND IMPROVES NEUROLOGICAL FUNCTION IN A MURINE MODEL OF SUBARACHNOID HEMORRHAGE
Wang C. - THE INFLUENCE OF THE HEMODIALYSIS PROCEDURES ON PLATELET AND HEMOSTATIC FUNCTIONS
Wang L. - PHENOTYPE AND FUNCTION OF CD4+CD25+ REGULATORY T CELLS IN MOUSE MODEL OF EXPERIMENTAL TRANSIENT IMMUNE THROMBOCYTOPENIA AFTER TREATMENT WITH INDIRUBIN
Wang S. - VENOUS THROMBOEMBOLISM IN CHINA: A SINGLE-CENTER EXPERIENCE FOR 11 YEARS
Wang N.C. - EVALUATION OF ORTHOSTATIC BALANCE AT GROUND AND SLOPE LEVELS IN ADULT PATIENTS WITH HAEMOPHILIA
Wang Z. - ALTERATIONS OF HEMOSTATIC PARAMETERS IN PATIENTS RECEIVING HEMATOPOIETIC STEM CELL TRANSPLANTATION
Wang X. - HEREDITARY COAGULATION FACTOR XIII DEFICIENCY CAUSED BY A DELETION MUTATION OF F13A GENE
Wang Z. - INHIBITION OF MEASURED THROMBIN GENERATION IN HUMAN PLASMA BY APIXABAN: A PREDICTIVE MATHEMATICAL MODEL BASED ON EXPERIMENTALLY DETERMINED RATE CONSTANTS
Wang H. - BERNARD-SOULIER PLATELETS EXPOSE MORE PROCOAGULANT PHOSPHATIDYLSERINE (PS), WITH PAR1 AND PAR4 MEDIATING THE SYNERGISTIC EFFECT OF THROMBIN ON COLLAGEN-STIMULATED PS EXPRESSION
Wang Z. - A HETEROZYGOUS MUTATION OF GPIIB IN PATIENT WITH GLANZMANN THROMBASTHENIA
Wang X. - THREE NOVEL MUTATIONS OF ANTITHROMBIN GENE WERE IDENTIFIED IN CHINESE FAMILIES
Wang H. - THREE NOVEL MUTATIONS OF ANTITHROMBIN GENE WERE IDENTIFIED IN CHINESE FAMILIES
Wang X. - SPERM MEDIATED HUMAN COAGULATION FACTOR VIII GENE TRANSFER AND EXPRESSION IN TRANSGENIC MICE
Wang H. - SPERM MEDIATED HUMAN COAGULATION FACTOR VIII GENE TRANSFER AND EXPRESSION IN TRANSGENIC MICE
Wang Y. - A NOVEL P2Y12 ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST THAT INHIBITS PLATELET AGGREGATION AND THROMBUS FORMATION IN RAT AND DOG MODELS
  - PLATELET FACTOR 4 EXERTS A NEGATIVE PARACRINE EFFECT ON MEGAKARYOPOIESIS THROUGH LIPOPROTEIN RELATED PROTEIN RECEPTOR-1 ON MEGAKARYOCYTIC PRECURSORS
Wang L. - THE CONSTRUCTION OF A HUMANIZED PHAGE ANTIBODY LIBRARY OF ANTI-PLATELET GPIIB/IIIA SINGLE CHAIN FV
Wang Z. - QUANTITATIVE ANALYSIS OF GENE EXPRESSION FOR VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS APPLICATION
Wang H. - CALDAG-GEFI-DEFICIENCY CAUSES IMPAIRED BETA1, BETA2, AND BETA3 INTEGRIN ACTIVATION IN NEUTROPHILS AND PLATELETS: A MODEL FOR LEUKOCYTE ADHESION DEFICIENCY-III (LAD-III)
Wang X. - THE SCREEN OF INHERITED ANTICOAGULANT PROTEINS DEFICIENCY AMONG NORMAL CHINESE
Wang H. - THE SCREEN OF INHERITED ANTICOAGULANT PROTEINS DEFICIENCY AMONG NORMAL CHINESE
Wang Q. - CONSTRUCTION AND IDENTIFICATION OF LENTIVIRUS - MEDIATED RNAI VECTORS CONTAINING HUMAN TISSUE FACTOR
Wang X. - FACTOR V MUTATIONS, SER234LEU AND ARG413CYS, ARE ASSOCIATED WITH FACTOR V DEFICIENCY AND A BLEEDING TENDENCY
Wang H. - FACTOR V MUTATIONS, SER234LEU AND ARG413CYS, ARE ASSOCIATED WITH FACTOR V DEFICIENCY AND A BLEEDING TENDENCY
Wang J.S. - VITAMIN E SUPPRESSES THROMBIN GENERATION INDUCED BY SYSTEMIC HYPOXIA
Wang Z. - HYPERFIBRINOLYTIC STATE IN ACUTE PROMYELOCYTIC LEUKEMIA ASSOCIATED WITH DISSEMINATED INTRAVASCULAR COAGULATION
Wang X. - ANTIPHOSPHOLIPID ANTIBODIES ASSOCIATED WITH MULTIPLE COAGULATION FACTOR DEFICIENCY IN SEVEN CHINESE PATIENTS
Wang H. - ANTIPHOSPHOLIPID ANTIBODIES ASSOCIATED WITH MULTIPLE COAGULATION FACTOR DEFICIENCY IN SEVEN CHINESE PATIENTS
Wang L. - LOW MOLECULAR WEIGHT HEPARIN IN PATIENTS WITH RENAL INSUFFICIENCY: ANALYSIS OF ANTI-XA LEVELS AND CREATININE CLEARANCE
Wang M. - LOW MOLECULAR WEIGHT HEPARIN IN PATIENTS WITH RENAL INSUFFICIENCY: ANALYSIS OF ANTI-XA LEVELS AND CREATININE CLEARANCE
Wang C.J. - LONG TERM OUTCOMES OF DEEP-VEIN THROMBOSIS IN ASIA AFTER MAJOR ORTHOPEDIC SURGERY: THE AIDA EXTENSION STUDY
Wang L. - CORRECTION OF TH1 DOMINANT CYTOKINE PROFILES BY HIGH DOSE DEXAMETHASONE IN PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA
Wang Y.X. - CORRECTION OF TH1 DOMINANT CYTOKINE PROFILES BY HIGH DOSE DEXAMETHASONE IN PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA
Wang X. - PREVALENCE OF PROTEIN S (PS), PROTEIN C (PC), ANTITHROMBIN (AT) DEFICIENCY AND ACTIVATED PC RESISTANCE (APC-R) IN THE CHINESE POPULATION
Wang H. - PREVALENCE OF PROTEIN S (PS), PROTEIN C (PC), ANTITHROMBIN (AT) DEFICIENCY AND ACTIVATED PC RESISTANCE (APC-R) IN THE CHINESE POPULATION
Wang X. - PREVALENCE OF PROTEIN S (PS), PROTEIN C (PC), ANTITHROMBIN (AT) DEFICIENCY AND ACTIVATED PC RESISTANCE (APC-R) IN THE CHINESE POPULATION
Wang Z. - PREVALENCE OF PROTEIN S (PS), PROTEIN C (PC), ANTITHROMBIN (AT) DEFICIENCY AND ACTIVATED PC RESISTANCE (APC-R) IN THE CHINESE POPULATION
Wang Q. - PHARMACOLOGICAL TARGETING OF PLATELETS BY ORALLY ACTIVE PI3-KINASE B INHIBITOR PROTECTS AGAINST ARTERIAL THROMBOSIS
Wang X. - COMBINED POLYMORPHISM MARKERS FOR CARRIER AND PRENATAL DIAGNOSIS OF HAEMOPHILIA IN CHINA
Wang H. - COMBINED POLYMORPHISM MARKERS FOR CARRIER AND PRENATAL DIAGNOSIS OF HAEMOPHILIA IN CHINA
Wang X. - RECOMBINATION IN ONE HAEMOPHILIA A FAMILY
Wang H. - RECOMBINATION IN ONE HAEMOPHILIA A FAMILY
Wang C. - JOINT RANGE OF MOTION (ROM) MEASUREMENTS IN PATIENTS WITH VON WILLEBRAND DISEASE COMPARED WITH NORMAL SUBJECTS
Wang X. - INVESTIGATIONS OF THROMBIN GENERATION TESTS IN WARFARIN-TAKING PATIENTS
Wang H. - INVESTIGATIONS OF THROMBIN GENERATION TESTS IN WARFARIN-TAKING PATIENTS
Wang L. - EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES
Wang X. - FUNCTIONAL ANALYSES OF THE LEU752ARG AND GLN891STOP ASSOCIATED WITH GLANZMANN THROMBASTHENIA
Wang H. - FUNCTIONAL ANALYSES OF THE LEU752ARG AND GLN891STOP ASSOCIATED WITH GLANZMANN THROMBASTHENIA
  - INFLUENCE OF BUYANG HUANWU DECOCTION COMBINED UNSATURAT FATTY ACID IN RATS WITH HYPERLIPIDEMIAED
Wang C.C. - SUPERWARFARIN INTOXIFICATION: HEMATURIA IS A MAJOR CLINICAL MANIFESTATION
Wang R. - CHANGES OF TISSUE FACTOR PATHWAY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Wang H. - INHIBITION OF AMINOPHOSPHOLIPID TRANSLOCASE ACTIVITY IN PHOSPHATIDYLSERINE-EXPOSING HUMAN PLATELETS IS INDEPENDENT OF CALPAIN ACTIVITY
Wang J. - ESTABLISHMENT OF A FLOW CYTOMETRIC ASSAY FOR QUANTITATIVE DETECTION OF HUMAN PLATLET GLYCOPROTEIN VI BY A MOUSE POLYCLONAL ANTIBODY
Ward C.M. - FIBRIN GENERATION IS NOT SUPPRESSED IN PATIENTS WARFARINISED FOR VENOUS THROMBOEMBOLISM (VTE)
  - THE ASSOCIATION OF DEPRESSION WITH PLATELET ACTIVATION: EVIDENCE FOR A TREATMENT EFFECT
  - ANALYSIS OF THE SENSITIVITY OF THE OVERALL HAEMOSTATIC POTENTIAL (OHP) ASSAY TO COAGULATION FACTORS
Ward D.P. - LACK OF EFFECT ON MARKERS OF THROMBIN GENERATION AND FIBRINOLYSIS BY PARTIAL FACTOR IXA INHIBITION FOLLOWING HIP FRACTURE SURGERY
Ward C.M. - A COMPARATIVE STUDY OF LOW MOLECULAR WEIGHT HEPARIN (LMWH) MONITORING BY ANTI-XA LEVELS, OVERALL HAEMOSTASIS POTENTIAL (OHP) AND CALIBRATED AUTOMATED THROMBOGRAM (CAT) ASSAYS
Ward D.P. - PREVENTION OF VENOUS THROMBOEMBOLISM VIA PARTIAL FACTOR IXA INHIBITION
Ware J. - RISTOCETIN-INDUCED AGGREGATION OF HUMAN GPIBALPHA TRANSGENIC MICE IS INHIBITED BY ANTI-HUMAN GPIBALPHA ANTIBODIES IN THE PRESENCE OF HUMAN PLASMA
Ware E. - INFLUENCE OF NANOPOLYMERS WITH DIFFERENT END-FUNCTIONALITIES ON PLATELETS AND COAGULATION. AN EX-VIVO STUDY
Ware J. - KLF4, A MODIFIER GENE IN GP6-NULL MICE
  - THE ROLE OF PLATELET GLYCOPROTEIN VI IN ARTERIAL THROMBOSIS
Warkentin T.E. - NASCOLA SURVEY OF HIT TESTING IN NORTH AMERICA
  - FACTORS INFLUENCING THE ANTI-PLATELET FACTOR 4/HEPARIN ANTIBODY (ANTI-PF4/H AB) IMMUNE RESPONSE: AN ANALYSIS OF FOUR RANDOMIZED CONTROLLED TRIALS (RCT'S) COMPARING ENOXAPARIN (ENOX) TO FONDAPARINUX (FONDA)
  - EVALUATION OF A PRE-TEST CLINICAL SCORE FOR THE DIAGNOSIS OF HIT
  - HEPARIN-INDUCED THROMBOCYTOPENIA (HIT): A PROSPECTIVE STUDY ON THE INCIDENCE, PLATELET-ACTIVATING CAPACITY AND CLINICAL SIGNIFICANCE OF ANTI-PLATELET FACTOR 4/HEPARIN ANTIBODIES (ANTI-PF4/H ABS) OF THE IGG, IGM, AND IGA CLASS
Warnock M. - THROMBOSTATIN FM19 - A THROMBIN RECEPTOR ACTIVATION ANTAGONIST
Warren M. - PHARMACOLOGICAL TARGETING OF PLATELETS BY ORALLY ACTIVE PI3-KINASE B INHIBITOR PROTECTS AGAINST ARTERIAL THROMBOSIS
Warrier I. - FIBRINOLYTIC PARAMETERS IN CHILDREN WITH NON-CATHETER RELATED DEEP VENOUS THROMBOSIS
  - INFLUENCE OF NANOPOLYMERS WITH DIFFERENT END-FUNCTIONALITIES ON PLATELETS AND COAGULATION. AN EX-VIVO STUDY
  - TISSUE PLASMINOGEN ACTIVATOR (RTPA) INDUCED FIBRINOLYSIS - STANDARDIZATION OF METHOD ON THROMBELASTOGRAPHY
Wartiovaara-Kautto U. - FRESH FROZEN PLASMA DOES NOT ATTENUATE COAGULATION ACTIVATION AFTER NEONATAL CARDIOPULMONARY BYPASS
Wartiovaara-Kautto U.M.K. - SIGNIFICANT DISTINCTION BETWEEN PLASMA- AND PLATELET-DEPENDENT COAGULATION ACTIVITY IN HEMOPHILIA A PATIENTS
Watala C. - P2Y12 ANTAGONIST COMPLEMENTARY TO ASPIRIN THERAPY IS SUPERIOR TO ASPIRIN ALONE IN PATIENTS AFTER CARDIOSURGERY OPERATIONS
Watala C.W. - HOW TO EFFECTIVELY MEASURE THE INHIBITION OF THROMBOXANE GENERATION BY ASPIRIN IN WHOLE CITRATED BLOOD?
Watala C. - THE METHODOLOGICAL PROBLEMS IN BLOOD PLATELET INVESTIGATION ARE STILL ACTUAL
Watanabe T. - REDUCTION OF ANTI-FIX INHIBITOR TITER IN A HEMOPHILIA B PATIENT WITH CONTINUOUS USE OF APCC
Watanabe H. - REDUCTION OF ANTI-FIX INHIBITOR TITER IN A HEMOPHILIA B PATIENT WITH CONTINUOUS USE OF APCC
Watanabe S. - ADAMTS13 AND VON WILLEBRAND FACTOR IN THE PATIENTS WITH DIC
Watanabe M. - LOCALIZATION AND EXPRESSION OF MYOSIN VI IN HUMAN HAEMATOPOIETIC CELLS INCLUDING PLATELETS
Watanabe G. - GENETIC FACTORS FOR DETERMINATION OF PLASMA VWF LEVELS IN A GENERAL POPULATION
Waters B. - THE SPLENIC MICRO-ENVIRONMENT AND FVIII-VWF INTERACTION ARE DETERMINANTS OF THE IMMUNOGENIC PRESENTATION OF FVIII BY DENDRITIC CELLS
  - ANTI-CD3 IN COMBINATION WITH NASAL FVIII-A2 DOMAIN DECREASES FVIII INHIBITORS
Watkins N.A. - A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP
  - NOVEL PLATELET TRANSMEMBRANE PROTEINS: IDENTIFICATION AND ANALYSIS
  - DIFFERENCES IN PLATELET RESPONSE TO ADP AND CRP ARE CORRELATED WITH VARIATION IN THE RESTING PLATELET TRANSCRIPTOME
  - MONOCYTE RESPONSE TO ACTIVATED PLATELETS: A TRANSCRIPTIONAL STUDY
Watson S.P. - COLLAGEN PROMOTES SUSTAINED GPVI SIGNALING IN PLATELETS AND CELL LINES
Watson C.A. - POTENT ANTITHROMBOTIC ACTIVITY OF APIXABAN, A DIRECT FACTOR XA INHIBITOR, WITH MINIMUM BLEEDING TIME EFFECT IN RABBIT MODELS OF ARTERIAL THROMBOSIS AND HEMOSTASIS
Watson S.P. - PLATELET ITIM PROTEINS INHIBIT BASAL SIGNALLING BY YXXL-CONTAINING PLATELET ACTIVATION RECEPTORS
  - CD148 IS A POSITIVE REGULATOR OF PLCGAMMA2 ACTIVATION BY GPVI
  - NOVEL PLATELET MEMBRANE RECEPTORS AND SIGNALLING PROTEINS
Watson C. - JOINT RANGE OF MOTION (ROM) MEASUREMENTS IN PATIENTS WITH VON WILLEBRAND DISEASE COMPARED WITH NORMAL SUBJECTS
Watson S.P. - A GADS-INDEPENDENT PATHWAY OF PLCGAMMA2 REGULATION DOWNSTREAM OF THE COLLAGEN RECEPTOR, GPVI
  - DYNAMIC SIGNALLING EVENTS AND FIBRIN-INDEPENDENT RETRACTION CONTRIBUTE TO THROMBUS STABILITY UNDER SHEAR
Watson H.G. - APPROACH TO THE DIAGNOSIS AND MANAGEMENT OF MILD BLEEDING DISORDERS
Watson S.P. - THE PLATELET ACTIVATION C-TYPE LECTIN RECEPTOR CLEC-2 SIGNALS VIA A NOVEL YXXL DEPENDENT SIGNALLING CASCADE DISTINCT FROM THAT OF ITAM RECEPTORS
  - IDENTIFICATION OF NOVEL TYROSINE PHOSPHORYLATED SIGNALLING PROTEINS FOLLOWING IIb3-MEDIATED PLATELET SPREADING: INVOLVEMENT OF THE IMMUNOGLOBULIN SUPERFAMILY MEMBERS G6B-B AND G6F, AND THE NOVEL PLATELET ADAPTER DOK-3
  - CONTRIBUTIONS OF COLLAGEN AND GLYCOPROTEIN VI SIGNALLING IN THE INTRINSIC PATHWAY OF COAGULATION
  - CD148 IS AN ESSENTIAL POSITIVE REGULATOR OF ITAM AND INTEGRIN RECEPTOR SIGNALLING IN PLATELETS
  - REDIAGNOSIS OF PLATELET "SECRETION" DISORDERS BY SIMULTANEOUS MEASUREMENT OF AGGREGATION AND ATP SECRETION
Watt G. - ORIENTIA TSUTSUGAMUSHI INFECTION (SCRUB TYPHUS) IS ASSOCIATED WITH AN INFRACLINICAL ACTIVATION OF THE COAGULATION SYSTEM BUT NOT WITH AN ACTIVATION OF ENDOTHELIAL CELLS
Watt S.G. - IN VIVO RECOVERY OF RISTOCETIN CO-FACTOR IN PATIENTS WITH VON WILLEBRAND DISEASE UNDERGOING PROCEDURES REQUIRING TREATMENT WITH HAEMATE P
  - AN AUDIT OF THROMBOPHILIA SCREENING IN A SINGLE PAEDIATRIC TERTIARY REFERRAL CENTRE
Watzka M. - COMBINED FACTOR V AND FACTOR VIII DEFICIENCY: MUTATION ANALYSIS AND ETHNICAL BACKGROUND OF FIVE PATIENTS
  - PHARMACOGENETICS OF ORAL ANTICOAGULATION - VKORC1-HAPLOTYPES DETERMINE THE INTER-INDIVIDUAL VARIABILITY
  - VKORC1: MOLECULAR TARGET OF COUMARINS
Waugh S. - N-GLYCAN SIALYLATION IS IMPORTANT FOR IN VIVO RECOVERY OF RECOMBINANT FACTOR IX
Wauters J. - RISK FACTORS PREDICTIVE OF CARDIOVASCULAR EVENTS IN AN INCIDENT DIALYSIS COHORT: A ROLE FOR HOMOCYSTEINEMIA AND ITS MTHFR GENOTYPE
Wautier M. - MESOTHELIAL RAGE ACTIVATION BY AGES ENHANCES VEGF RELEASE AND POTENTIATES CAPILLARY TUBE FORMATION
Wautier J. - MESOTHELIAL RAGE ACTIVATION BY AGES ENHANCES VEGF RELEASE AND POTENTIATES CAPILLARY TUBE FORMATION
Wautier M. - INCREASED ADHESION TO ENDOTHELIAL CELLS OF ERYTHROCYTES FROM PATIENTS WITH POLYCYTHEMIA VERA IS MEDIATED BY LAMININ ALPHA5 CHAIN AND LU/BCAM
Wautier J. - INCREASED ADHESION TO ENDOTHELIAL CELLS OF ERYTHROCYTES FROM PATIENTS WITH POLYCYTHEMIA VERA IS MEDIATED BY LAMININ ALPHA5 CHAIN AND LU/BCAM
Wautrecht J. - IS D-DIMER TESTING COST-EFFECTIVE IN ELDERLY PATIENTS CLINICALLY SUSPECTED OF DEEP VEIN THROMBOSIS?
Waye J.S. - IDENTIFICATION OF A LOCUS FOR THE QUEBEC PLATELET DISORDER USING GENETIC LINKAGE ANALYSIS
Weaver F. - PHASE 3 STUDY COMPARING RECOMBINANT HUMAN THROMBIN AND BOVINE THROMBIN FOR SURGICAL HEMOSTASIS
Weber A. - BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF CHEMICALLY MODIFIED RECOMBINANT VON WILLEBRAND FACTOR (RVWF) AS A CARRIER PROLONGING SURVIVAL OF RFVIII IN HEMOPHILIA A KNOCK-OUT MICE
Weber H. - COMPARISON OF DIFFERENT METHODS FOR ISOLATION AND STORAGE OF MICROPARTICLES FROM HUMAN BLOOD
Weber J. - MEGAKARYOCYTE-RESTRICTED MYH9 INACTIVATION DRAMATICALLY AFFECTS HAEMOSTASIS WHILE PRESERVING PLATELET AGGREGATION AND SECRETION RESPONSES
Webert K. - EFFICACY OF TEACHING CLINICAL CLERKS AND RESIDENTS ABOUT MANAGEMENT OF BLEEDING AND COAGULATION DISORDERS USING E-LEARNING
  - HIGH PREVALENCE OF IRON DEFICIENCY AMONG PATIENTS REFERRED FOR EVALUATION OF A BLEEDING DISORDER
Webert K.E. - GLOBAL ASSAYS OF PLATELET FUNCTION IN DIAGNOSTIC TESTING
Webster S. - EXERCISE IMPROVES THE GLOBAL HEMOSTATIC EFFICACY IN SEVERE HEMOPHILIA A DOGS, AS DETERMINED BY THROMBELASTOGRAPHY
Wedgewood K. - CHEMOANTICOAGULATION VERSUS CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): RESULTS OF THE INTERIM ANALYSIS OF THE FRAGEM TRIAL
Wee J.L. - IMPAIRED 'OUTSIDE-IN' INTEGRIN ALPHAIIBBETA3 SIGNALING AND THROMBUS STABILITY IN CD151 AND TSSC6-DEFICIENT MICE
Weening J.J. - UPAR IS AN IMPORTANT MODULATOR OF TUBULAR REPAIR AFTER RENAL ISCHEMIA REPERFUSION INJURY
Weeterings C. - PSGL1 AND LDL-RECEPTORS MEDIATE ADHESION OF LEUKOCYTES TO BETA2-GLYCOPROTEIN-I
  - GLYCOPROTEIN IB-ALPHA CONTRIBUTES TO TISSUE FACTOR-INDEPENDENT THROMBIN GENERATION BY RECOMBINANT FACTOR VIIA ON THE ACTIVATED PLATELET SURFACE
Wegert W. - INTRA-SUBJECT VARIABILITY OF THROMBOELASTOGRAPHIC PARAMETERS FOLLOWING RFVIIA IN VIVO ADMINISTRATION IN HAEMOPHILIA PATIENTS: A MULTI-CENTRE, RANDOMIZED TRIAL
  - TESTING FVIIA EFFICACY AS A POTENTIAL TREATMENT FOR PATIENTS WITH HERMANSKY-PUDLAK-SYNDROME TYPE 1 (HPS-1) WITH A THROMBIN GENERATION TEST (TGT) IN TWO CASES
  - EFFECT OF RFVIIA (NOVOSEVEN,) AND FEIBA (FACTOR EIGHT INHIBITOR BYPASSING ACTIVITY) ON ANTICOAGULANT-INDUCED INHIBITION OF THROMBIN GENERATION IN PLATELET-RICH PLASMA (PRP)
Wegrzyn W. - THE ADDITIVE ANTIPLATELET ACTION OF CLOPIDOGREL IN PATIENTS WITH CORONARY ARTERY DISEASE TREATED WITH ASPIRIN
Wehrle-Haller B. - FACTOR VII ACTIVATING PROTEASE (FSAP) REGULATES CELL ADHESION AND MOTILITY BY MULTIPLE MECHANISMS
Wei X. - PREVALENCE OF PROTEIN S (PS), PROTEIN C (PC), ANTITHROMBIN (AT) DEFICIENCY AND ACTIVATED PC RESISTANCE (APC-R) IN THE CHINESE POPULATION
  - THE SCREEN OF INHERITED ANTICOAGULANT PROTEINS DEFICIENCY AMONG NORMAL CHINESE
Weickardt S. - VARIABILITY IN PERFORMING PLATELET AGGREGOMETRY FOR DIAGNOSIS OF INBORN DISORDERS OF PLATELET FUNCTION IN GERMANY, AUSTRIA AND SWITZERLAND
  - DIAGNOSIS AND THERAPY OF CHILDREN WITH INHERITED DEFECTS OF PLATELET FUNCTION IN GERMAN SPEAKING COUNTRIES: QUALITY PROJECT THROMKID
Weidenhammer A. - PHYSICAL EXAMINATION IN PATIENTS WITH SEVERE HEMOPHILIA UNDER PROPHYLACTIC TREATMENT - EFFICACY OF AN EARLY LONG-TERM PROPHYLAXIS?
  - THE CHALLENGE OF PRAEOPERATIVE INVESTIGATION OF HEREDITARY AND ACQUIRED COAGULATION DISORDERS IN CHILDREN AND ADOLESCENTS
Weiler H. - MATERNAL PLATELETS AND THE THROMBIN RECEPTOR, PAR4, DISRUPT PLACENTAL MORPHOGENESIS AND CAUSE FETAL LOSS IN FACTOR V LEIDEN MICE
  - FIBRIN A-ALPHA PEPTIDE MEDIATED DELIVERY OF BIOLOGICALLY ACTIVE PROTEINS
  - THE THROMBOMODULIN PROTEIN C SYSTEM PROTECTS AGAINST DIABETIC NEUROPATHY VIA TWO INDEPENDENT MECHANISMS
  - TRANSPLANT BONE MARROW THAT IS GENETICALLY MODIFIED TO EXPRESS FVIII ONLY IN PLATELETS CAN RESTORE HEMOSTASIS TO HEMOPHILIA A MICE ON A STRONG INHIBITOR BACKGROUND
Weimer T. - STRUCTURE-FUNCTION ANALYSIS OF THE BINDING PROPERTIES AND ENZYMATIC ACTIVITY OF FACTOR VII ACTIVATING PROTEASE (FSAP) USING RECOMBINANT MUTANT PROTEINS
Weinberger S. - HIGH INCIDENCE OF CLOPIDOGREL NON-RESPONSIVENESS IN PATIENTS WITH CORONARY ARTERY DISEASE A REAL WORLD SITUATION
Weinberger J. - VWF:RCO ASSAYS USING AUTOMATED SYSTEMS FOR VWF/FVIII CONCENTRATES REQUIRE ADJUSTMENT OF ASSAY REAGENTS, COMPOSITION AND PERFORMANCE PARAMETERS
Weinstein M. - REPORT OF THE SC-VWF WORKING PARTY ON VWF ASSAYS IN VWD DIAGNOSES
Weintraub M. - ISRAELI PEDIATRIC ONCOLOGY REGISTRY ON CENTRAL VENOUS LINE RELATED COMPLICATIONS
Weippert-Kretschmer M. - PLATELET THROMBUS GROWTH ANGLE (PTGA) VERSUS CLOSURE TIME (CT) IN VON WILLEBRAND PATIENTS TYPE I AS MEASURED WITH THE PLATELET FUNCTION ANALYSER
Weise M. - HIT II-INDUCED CRITICAL LIMB ISCHAEMIA TREATED WITH UROKINASE AND ARGATROBAN
Weise-Kelly L. - RECURRENT DEEP VEIN THROMBOSIS (DVT) IS EXCLUDED BY A NEGATIVE D-DIMER OR SERIAL COMPRESSION ULTRASONOGRAPHY (CUS): RESULTS OF A MULTICENTER MANAGEMENT STUDY
Weisel J.W. - DO B:b INTERACTIONS HAVE A ROLE IN FIBRIN POLYMERIZATION?
  - DIFFERENT INTEGRINS, DIFFERENT STATES, DIFFERENT SHAPES?
  - STRUCTURE OF FIBRIN: IMPACT ON CLOT STABILITY
  - DIRECT EVIDENCE OF SPECIFIC INTERACTIONS OF FIBRINOGEN ALPHA C REGIONS WITH THE CENTRAL E REGION AND WITH EACH OTHER
  - DYNAMICS OF DISINTEGRIN DISRUPTION OF INTEGRIN STRUCTURE AND FUNCTION
Weisel J. - PRONOUNCED B KNOB CAPACITY TO MODULATE FIBRIN ARCHITECTURE, STIFFNESS, AND PLASMIN LYSIS
  - EFFECT OF HOMOCYSTEINE ON CLOT STRUCTURE AND FIBRINOLYSIS
Weisel J.W. - THE EFFECT OF FIBRINOGEN GLYCATION ON FIBRIN NETWORK STRUCTURE OF TYPE II DIABETIC SUBJECTS
Weiss A. - CD148 IS A POSITIVE REGULATOR OF PLCGAMMA2 ACTIVATION BY GPVI
Weiss C. - LONG LASTING ANTICOAGULANT EFFECTS OF ONCE WEEKLY SUBCUTANEOUS INJECTIONS OF IDRAPARINUX TO TREAT PATIENTS FOR PROPHYLAXIS OF RECURRENT VENOUS THROMBOEMBOLISM
Weiss I. - ADAMTS13 ACTIVITY AND AUTOANTIBODIES IN IDIOPATHIC TTP: RESULTS FROM THE SERF-TTP GROUP
  - RISK FACTORS FOR THROMBOTIC THROMBOCYTOPENIC PURPURA: RESULTS OF THE SURVEILLANCE, EPIDEMIOLOGY AND RISK FACTORS FOR TTP (SERF-TTP) GROUP
Weiss E. - THROMBIN GENERATION IN NORMAL UNCOMPLICATED PREGNANCY
Weiss A. - CD148 IS AN ESSENTIAL POSITIVE REGULATOR OF ITAM AND INTEGRIN RECEPTOR SIGNALLING IN PLATELETS
Weisser H. - IMPACT OF CENTRIFUGATION CONDITIONS ON PLATELETS AND COAGULATION TESTING
  - PLATELET RESPONSIVENESS TOWARDS ANTIPLATELET MEDICATIONS BEFORE AND AFTER CORONARY ANGIOGRAPHY AND PERCUTENOUS CORONARY INTERVENTIONS AS DETERMINED BY WHOLE BLOOD AGGREGOMETRY
Weitz J.I. - ANTICOAGULANT PROPERTIES OF HD1, A (PRO)THROMBIN-DIRECTED DNA APTAMER
  - COVALENT ANTITHROMBIN-HEPARIN COMPLEX REDUCES BRAIN EMBOLI DURING HYPOTHERMIC CARDIOPULMONARY BYPASS IN PIGS
  - ZINC PROMOTES FORMATION OF TERNARY THROMBIN-FIBRIN-HEPARIN COMPLEXES BY ENHANCING HEPARIN-FIBRIN AFFINITY
  - COMPARISON OF IMPEDANCE WHOLE BLOOD AGGREGATION AND OPTICAL PLATELET-RICH PLASMA AGGREGATION TO MEASURE THE ANTIPLATELET EFFECT OF ASPIRIN IN HEALTHY CONTROLS AND IN PATIENTS WITH PERIPHERAL ARTERY DISEASE (PAD)
  - FACTOR XA OR THROMBIN: IS THROMBIN A BETTER TARGET?
  - BIVALENT BINDING OF THROMBIN TO GAMMA'-FIBRIN ENHANCES PROTECTION FROM INHIBITION BY ANTITHROMBIN-HEPARIN
  - HISTIDINE-RICH GLYCOPROTEIN (HRG) MODULATES THE FUNCTION OF FXII IN HEMOSTASIS
Weksler B.B. - TOBACCO SMOKE COOPERATES WITH INTERLEUKIN-1B TO ALTER B-CATENIN TRAFFICKING IN VASCULAR ENDOTHELIUM RESULTING IN INCREASED PERMEABILITY AND INDUCTION OF CYCLOOXYGENASE-2 EXPRESSION IN VITRO AND IN VIVO
Welch C.A. - CORONARY ARTERY BYPASS GRAFTING (CABG) IN PATIENTS WITH IMMUNE THROMBOCYTOPENIC PURPURA (ITP)
  - THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) FOLLOWING CARDIAC SURGERY: AN EMERGING SYNDROME
Welke K. - ABNORMAL PLATELET FUNCTION IS COMMON IN PEDIATRIC CONGENITAL CARDIAC SURGERY PATIENTS
Wells P. - RISK OF VENOUS THROMBOEMBOLISM (VTE) IN FIRST DEGREE RELATIVES (FDRS) OF PATIENTS WITH UNPROVOKED VTE WHO DO NOT HAVE FACTOR V LEIDEN (FVL) OR THE G20210A PROTHROMBIN GENE MUTATION (PGM)
  - EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES
Wells P.S. - SCREENING FOR OCCULT MALIGNANCY IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOEMBOLISM (VTE) EVALUATION (SOME TRIAL): A PROSPECTIVE PILOT COHORT STUDY USING COMPREHENSIVE ABDOMEN/PELVIS COMPUTED TOMOGRAPHY (CCT)
  - ECONOMIC EVALUATION OF POINT-OF-CARE MONITORING DEVICES FOR LONG-TERM ORAL ANTICOAGULATION THERAPY
  - DEFINING BENEFIT-RISK TRADEOFF VALUES FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS AFTER ORTHOPEDIC SURGERY (OS)
  - IMPACTS OF GENETIC TESTING FOR THROMBOPHILIA ON FIRST DEGREE RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND A THROMBOPHILIA - A CROSS-SECTIONAL SURVEY
  - ACCURACY AND USEFULNESS OF A CLINICAL PREDICTION RULE AND D-DIMER TESTING IN EXCLUDING DEEP VEIN THROMBOSIS (DVT) IN CANCER PATIENTS
  - DO POINT OF CARE DEVICES IMPROVE OUTCOMES IN PATIENTS ON ORAL ANTICOAGULANT THERAPY
  - VERY LOW FREQUENCY OF HEPARIN INDUCED THROMBOCYTOPENIA (HIT) IN A TERTIARY CARE HOSPITAL
  - INTEGRATED DIAGNOSTIC STRATEGY FOR VENOUS THROMBOEMBOLISM
  - A PILOT STUDY TO ASSESS THE FEASIBILITY OF A MULTICENTER TRIAL FOR THE MANAGEMENT OF ASYMPTOMATIC PERSONS WITH A THROMBOPHILIA
  - PSYCHOLOGICAL IMPACTS OF GENETIC TESTING FOR THROMBOPHILIA ON FIRST DEGREE RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND A THROMBOPHILIA A PILOT STUDY
  - FURTHER VALIDATION AND SIMPLIFICATION OF THE WELLS CLINICAL DECISION RULE IN PULMONARY EMBOLISM
  - A COMPARISON OF ANTICOAGULANTS (AC) FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS (PROPH) AFTER ORTHOPEDIC SURGERY (OS) USING A CLINICAL COST-EFFECTIVENESS ANALYSIS (CEA) APPROACH
  - SECULAR TRENDS IN STUDIES EVALUATING VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS AFTER ORTHOPEDIC SURGERY (OS)
  - FACTOR V LEIDEN (FVL) AND PROTHROMBIN GENE VARIANT (PGV) MAY BE ONLY WEAKLY ASSOCIATED WITH PLACENTA MEDIATED PREGNANCY COMPLICATIONS: A LARGE PROSPECTIVE COHORT STUDY
Wells P. - EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY
Welsh P. - COMPARISON OF THE ASSOCIATIONS BETWEEN HAEMOSTATIC AND INFLAMMATORY VARIABLES AND CHD RISK: FLETCHER CHALLENGE STUDY
Weltermann A. - CISPLATIN INDUCES IN VITRO THROMBIN GENERATION VIA FORMATION OF PROCOAGULANT ENDOTHELIAL MICROPARTICLES
  - COMPARISON OF DIFFERENT METHODS FOR ISOLATION AND STORAGE OF MICROPARTICLES FROM HUMAN BLOOD
  - SPONTANEOUS DEEP VEIN THROMBOSIS OF THE UPPER EXTREMITIES: RISK FACTORS AND LONG TERM FOLLOW UP
Wemyss A. - ANTI XA ASSAYS FOR DANAPAROID: ASSESSMENT OF PRE ANALYTICAL AND ANALYTICAL VARIABLES
Wen B. - CHANGES OF TISSUE FACTOR PATHWAY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Wen Z. - INFLUENCE OF BUYANG HUANWU DECOCTION COMBINED UNSATURAT FATTY ACID IN RATS WITH HYPERLIPIDEMIAED
  - EFFECT OF TETRAMETHYLPYRAZINE ON THE EXPRESSION OF TISSUE FACTOR INDUCED BY THROMBIN AND ITS MECHANISM
Wen Z.B. - STUDY ON THE DETECTION AND APPLICATION OF THE LEVEL OF TISSUE FACTOR PATHWAY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND CEREBRAL INFARCTION
Wen Z. - SIGNAL TRANSDUCTION PATHWAYS OF INTERLEUKIN-6 INDUCING TISSUE FACTOR EXPRESSION IN VASCULAR ENDOTHELIAL CELLS
Wendel H.P. - HUMAN VASCULAR ENDOTHELIAL CELLS INFLUENCE THE WHOLE BLOOD THROMBIN GENERATION ASSAY
Wentworth S. - COMPARISON OF TWO ASSAYS FOR THE MEASUREMENT OF URINARY 11-DEHYDRO THROMBOXANE B2
Werba P. - ASSOCIATION OF TISSUE FACTOR A-603G GENOTYPE WITH CAROTID INTIMA-MEDIA THICKNESS IN SUBJECTS IN CARDIOVASCULAR RISK PREVENTION
Wermert D. - RISK FACTORS AND CLINICAL SIGNIFICANCE OF RESIDUAL PERFUSION DEFECTS AFTER SYMPTOMATIC PULMONARY EMBOLISM
Wermes C. - DIAGNOSIS AND THERAPY OF CHILDREN WITH INHERITED DEFECTS OF PLATELET FUNCTION IN GERMAN SPEAKING COUNTRIES: QUALITY PROJECT THROMKID
  - PROSPECTIVE POST LICENSURE SURVEILLANCE OF EFFICACY AND TOLERABILITY OF A HIGH PURITY, DOUBLE VIRUS INACTIVATED VWF/FVIII CONCENTRATE IN THE TREATMENT OF VON WILLEBRAND'S DISEASE
Wessel A. - HEPARIN-INDUCED THROMBOCYTOPENIA (HIT): A PROSPECTIVE STUDY ON THE INCIDENCE, PLATELET-ACTIVATING CAPACITY AND CLINICAL SIGNIFICANCE OF ANTI-PLATELET FACTOR 4/HEPARIN ANTIBODIES (ANTI-PF4/H ABS) OF THE IGG, IGM, AND IGA CLASS
Wessela S. - INCIDENCE AND DISEASE PATTERN OF VENOUS THROMBEMBOLISM AFTER RADICAL PROSTATECTOMY
Wessels C. - INDUCTION OF ENDOTHELIAL CELL HYPERPERMEABILITY BY EXTRACELLULAR RNA
Wessman P. - SAFETY AND TOLERABILITY OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 IN PREVENTION OF STROKE AND OTHER THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH ATRIAL FIBRILLATION (AF)
West A. - FACTOR V AND THROMBIN INHIBITORS IN CHILDREN FOLLOWING BOVINE THROMBIN EXPOSURE
Westein E. - IDENTIFICATION OF A NOVEL MECHANISM PROMOTING STATIONARY ADHESION OF DISCOID PLATELETS SHEAR DEPENDENT CONVERSION OF PLATELET TETHERS TO PSEUDOPODIA
  - HIGH RESOLUTION IMAGING OF PLATELETS IN VITRO AND IN VIVO
Wester J.P.J. - COAGULATION PARAMETERS OF THE ISTH OVERT DIC SCORE: FIRST, THEIR DISTRIBUTION
Westerbeek R.E. - DIRECT THROMBUS IMAGING WITH MAGNETIC RESONANCE IN THE DISCRIMINATION BETWEEN ACUTE AND CHRONIC DEEP VEIN THROMBOSIS; A PROSPECTIVE PROOF-OF-PRINCIPLE STUDY
Western H. - VITAMIN K DEFICIENCY IN PATIENTS WITH CANCER REFERRED TO A HOSPITAL PALLIATIVE CARE TEAM
Westrick R.J. - MATERNAL PLATELETS AND THE THROMBIN RECEPTOR, PAR4, DISRUPT PLACENTAL MORPHOGENESIS AND CAUSE FETAL LOSS IN FACTOR V LEIDEN MICE
  - AN ENU MUTAGENESIS SCREEN FOR DOMINANT GENETIC MODIFIERS OF THROMBOSIS IN THE FACTOR 5 LEIDEN MOUSE
Westwood J. - USE OF RECOMBINANT ACTIVATED FACTOR VIIA (RFVIIA) IN MASSIVE HAEMORRHAGE
Wexler R.R. - POTENT ANTITHROMBOTIC ACTIVITY OF APIXABAN, A DIRECT FACTOR XA INHIBITOR, WITH MINIMUM BLEEDING TIME EFFECT IN RABBIT MODELS OF ARTERIAL THROMBOSIS AND HEMOSTASIS
Wheeler M.L. - A POTENTIAL SOURCE OF ERRONEOUS RESULTS ON AUTOMATED COAGULATION ANALYSERS - AN OBSERVATIONAL STUDY
Whinna H.C. - RNA APTAMER-DIRECTED ANTICOAGULANT THERAPY
White R. - EXPLORING ADULT PATIENT POPULATIONS AT RISK FOR DEVELOPING HIT
White T.C. - THE LEECH PRODUCT SARATIN IS A POTENT INHIBITOR OF PLATELET INTEGRIN ALPHA2BETA1 AND VWF BINDING TO COLLAGEN
White B. - ONCE DAILY TINZAPARIN SODIUM (175 INTERNATIONAL UNITS PER KG) IS SAFE AND EFFECTIVE FOR ANTENATAL THROMBOPROPHYLAXIS IN HIGH RISK PREGNANCIES AND FOR TREATMENT OF ANTENATAL VENOUS THROMBOEMBOLIC EVENTS
White G.C. - RAP1B IS REQUIRED FOR NORMAL ANGIOGENESIS AND MAPK SIGNALING IN ENDOTHELIAL CELLS
White A.E. - COMPARISON OF THE EFFECTS OF THE P2Y14 RECEPTOR AGONIST UDP-GLUCOSE AND THE EP3 RECEPTOR AGONIST SULPROSTONE ON PLATELET FUNCTION
White R.H. - LONG TERM OUTCOMES AMONG PATIENTS UNDER THE AGE OF 55 YEARS WHO ARE DIAGNOSED WITH FIRST-TIME IDIOPATHIC PULMONARY EMBOLISM (PE)
White R. - SUCCESSFUL ANTICOAGULATION OF INFANTS TO ADULTS WITH BIVALIRUDIN IN EXTRACORPOREAL MEMBRANOUS OXYGENATION (EMCO)
White R.H. - LOW-DOSE (1.2MG) RFVIIA TO REVERSE WARFARIN THERAPY IN CRITICALLY ILL PATIENTS WITH MAJOR BLEEDING
White A. - PLATELET AGGREGATION IS ENHANCED UNDER CONDITIONS OF HYPOTHERMIA
White B. - PROCOAGULANT EFFECTS OF NEOADJUVANT CHEMORADIATION FOR OESOPHAGEAL CANCER
White T.C. - THE THROMBIN MUTANT W215A/E217A ACTS AS A PLATELET ANTAGONIST THROUGH INHIBITION OF THROMBIN ACTIVATION AND GPIB BINDING TO VWF
White R.H. - IMPROVING PATIENT SAFETY WHEN STARTING WARFARIN IN THE HOSPITAL: THE WARFDOCS STUDY
White A.E. - RAISED LEVELS OF CD39 IN LEUCOCYTOSIS RESULT IN MARKED INHIBITION OF ADP-INDUCED PLATELET AGGREGATION VIA RAPID ADP HYDROLYSIS
White R.H. - COMPARISON OF THE INCIDENCE OF RECURRENT VENOUS THROMBOEMBOLISM AFTER PREGNANCY-ASSOCIATED VTE VERSUS IDIOPATHIC VTE
  - HIGH RISK FOR VENOUS THROMBOEMBOLISM IN DIABETICS WITH HYPEROSMOLAR STATE: COMPARISON WITH OTHER ACUTE MEDICAL ILLNESSES
White J.G. - SEROTONIN ENHANCES THE PROCOAGULANT PROPERTIES AND PLATELET ACTIVATION INDUCED DURING PLATELET UP TAKE OF TISSUE FACTOR
White M.M. - GPIIB-IIIA ANTAGONISTS HAVE A SIGNIFICANT EFFECT ON THROMBUS STABILITY BY DISPLACING BOUND FIBRINOGEN
White R.H. - COMPARISON OF THE 30-DAY INCIDENCE OF ISCHEMIC STROKE AND BLEEDING AFTER MAJOR SURGERY IN PATIENTS WITH AND WITHOUT ATRIAL FIBRILLATION (AF)
White J.G. - THE CRITICAL ROLE OF MYOSIN IIA IN PLATELET INTERNAL CONTRACTION
White T.C. - FACTOR XI MEDIATES PLATELET LAMELLIPODIA FORMATION AND TETHERING AND ROLLING UNDER SHEAR CONDITIONS
White R. - VENOUS THROMBOEMBOLISM IN ACUTE LEUKEMIA PATIENTS: INCIDENCE, RISK FACTORS, AND MORTALITY
White T.C. - GLYCOPROTEIN Ib MEDIATES PLATELET RECRUITMENT, ACTIVATION AND AGGREGATION ON IMMOBILIZED PROTEIN C AND ACTIVATED PROTEIN C UNDER SHEAR
White R. - CAUSE OF DEATH AMONG PATIENTS WITH LOCAL OR REGIONAL STAGE CANCER OF THE BREAST AND LUNG WHO DEVELOP VENOUS THROMBOEMBOLISM (VTE)
White R.H. - EFFECT OF SURGICAL PROCEDURES AND SPECIFIED RISK FACTORS ON THE INCIDENCE OF PERI-OPERATIVE STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF)
Whitsett T. - A PHASE II DOUBLE-BLIND PLACEBO-CONTROLLED PARALLEL-GROUP RANDOMIZED STUDY OF EXTENDED PROPHYLAXIS WITH ODIPARCIL FOLLOWING TOTAL HIP ARTHROPLASTY (THA)
Whittaker P. - LONG-TERM WARFARIN THERAPY IS ASSOCIATED WITH TISSUE CALCIFICATION: INFLUENCE OF TREATMENT DURATION, AGE, AND GENDER
  - QUANTITATIVE ASSESSMENT OF FIBRIN ARCHITECTURE: NOVEL TECHNIQUES AND STAINING METHODS
  - REDUCTION IN EMERGENCY DEPARTMENT VISITS BY PATIENTS ATTENDING AN ANTICOAGULATION CLINIC
Whittaker S. - GLOBAL ASSAYS OF PLATELET FUNCTION IN DIAGNOSTIC TESTING
  - HIGH PREVALENCE OF IRON DEFICIENCY AMONG PATIENTS REFERRED FOR EVALUATION OF A BLEEDING DISORDER
Wice S.M. - ORALLY ADMINISTERED HEPARIN HAS CUMULATIVE ANTITHROMBOTIC EFFECTS WHEN ADMINISTERED IN REPEATED DOSES
Wichers I.M. - DETERMINANTS OF THE ENDOGENOUS THROMBIN POTENTIAL IN A DUTCH THROMBOPHILIC FAMILY
Wicklund B.M. - U.S. INHIBITOR PILOT PROJECT: STUDY DESIGN AND METHODS VALIDATION
Wickström M. - ANTIAPOPTOTIC SIGNALING BY TF/FVIIA IS INHIBITED BY SIMVASTATIN
Widemann A. - IMMUNO-MAGNETIC ENRICHMENT FOLLOWED BY MULTI-PARAMETER FLOW CYTOMETRY: A NEW APPROACH TO COUNT CIRCULATING ENDOTHELIAL CELLS
Wiebe B. - CATHETER-RELATED THROMBOSES IN NEWBORNS
Wiebe W. - CATHETER-RELATED THROMBOSES IN NEWBORNS
Wiedemann P. - ROLE OF THROMBOPHILIC RISK FACTORS IN PATIENTS WITH RETINAL VEIN OCCLUSION
Wiegand G. - ASPIRIN-RESISTANCE IN CHILDREN
  - ANTICOAGULATION IN CHILDREN WITH DISTAL SPLENORENAL SHUNT (WARREN SHUNT) OR MESENTERICO- LEFT PORTAL SHUNT (REX SHUNT)
Wiek I. - CONTRIBUTION OF ALPHA-FIBRINOGEN A312 ALLELE TO DECREASED THROMBIN GENERATION IN PATIENTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING SURGERY
Wiener C. - SPONTANEOUS DEEP VEIN THROMBOSIS OF THE UPPER EXTREMITIES: RISK FACTORS AND LONG TERM FOLLOW UP
Wiesenburg A. - FIRST EXPERIENCE WITH THROGA (THROMBIN GENERATION ASSAY) IN IDENTIFICATION OF HYPER- AND HYPOCOAGULABILITY
Wiggins K.L. - ESTROGEN USE, VARIANTS IN 24 CLOTTING GENES AND THE RISK OF THROMBOSIS IN POSTMENOPAUSAL WOMEN
Wiinberg B. - PROSPECTIVE DESIGN OF A NEW, OBJECTIVE SCORING SYSTEM FOR IDENTIFYING DISSEMINATED INTRAVASCULAR COAGULATION IN DOGS A SPONTANEOUS ANIMAL MODEL
Wijers-Holys P.A. - THROMBIN GENERATION AND COAGULATION MARKERS IN PATIENTS WITH A FIRST ACUTE MYOCARDIAL INFARCTION
  - THROMBOXANE B2 IN PATIENTS WITH A FIRST ACUTE MYOCARDIAL INFARCTION: THE INFLUENCE OF TREATMENT WITH ACETYLSALICYLIC ACID
Wijeyeratne Y.D. - COMPARISON OF THE EFFECTS OF THE P2Y14 RECEPTOR AGONIST UDP-GLUCOSE AND THE EP3 RECEPTOR AGONIST SULPROSTONE ON PLATELET FUNCTION
Wijns W. - THE DISTURBED MULTIMER PATTERN OF VWF R1374C IS NOT DUE TO INCREASED ADAMTS13 MEDIATED PROTEOLYSIS
Wilaschek M. - SUCCESSFUL ANGIOGRAPHIC EMBOLIZATION OF RECURRENT ELBOW JOINT BLEEDS IN FIVE PATIENT WITH SEVERE HAEMOPHILIA A
Wilcox D.A. - CORRECTION OF HAEMORRHAGIC DISORDERS AFFECTING PLATELETS: GENE THERAPY RESTORES HEMOSTASIS WITHIN A CANINE MODEL FOR GLANZMANN THROMBASTHENIA
  - TRANSPLANT BONE MARROW THAT IS GENETICALLY MODIFIED TO EXPRESS FVIII ONLY IN PLATELETS CAN RESTORE HEMOSTASIS TO HEMOPHILIA A MICE ON A STRONG INHIBITOR BACKGROUND
Wilcox D. - RECOMBINANT HUMAN HPA-1A ANTIBODIES FOR TREATMENT OF FETO-MATERNAL ALLO-IMMUNE THROMBOCYTOPENIA (FMAIT): PROOF OF PRINCIPLE IN AN IN VIVO MURINE MODEL
Wilde J.T. - HETEROGENEOUS SEQUENCE CHANGES IN THE PROMOTER AND CODING SEQUENCE OF THE FACTOR VIII GENE IDENTIFIED IN 247 FAMILIES FROM THE UK
Wilde J. - REDIAGNOSIS OF PLATELET "SECRETION" DISORDERS BY SIMULTANEOUS MEASUREMENT OF AGGREGATION AND ATP SECRETION
Wiles K.G. - SKIZZLE, A NOVEL PLASMIN(OGEN) BINDING PROTEIN AND PLASMINOGEN ACTIVATOR FROM STREPTOCOCCUS AGALACTIAE
Wilke N. - THE PLAQUE LIPID LYSOPHOSPHATIDIC ACID STIMULATES PLATELETS NOT THROUGH THE LPA1, LPA2 AND LPA3 RECEPTOR
Will A. - AN AUDIT OF THROMBOPHILIA SCREENING IN A SINGLE PAEDIATRIC TERTIARY REFERRAL CENTRE
Willemse J.L. - GENERATION OF CARBOXYPEPTIDASE U (TAFIA) IN ISCHEMIC STROKE PATIENTS RECEIVING THROMBOLYTIC THERAPY
  - THE ZYMOGEN PROCARBOXYPEPTIDASE U (TAFI) DOES NOT INFLUENCE THE FIBRINOLYTIC RATE
  - TRANEXAMIC ACID DELAYS THE CLOT LYSIS TIME, AND INCREASES THE ENDOGENOUS THROMBIN GENERATION AND PLASMA PROCARBOXYPEPTIDASE U (TAFI) LEVELS IN PATIENTS WITH MUCOCUTANEOUS BLEEDING
  - SUBSTRATE SPECIFICITY STUDY OF CARBOXYPEPTIDASE U (TAFIA): DEVELOPMENT OF HIGHLY SELECTIVE CPU SUBSTRATES AS USEFUL TOOLS FOR ASSAY DEVELOPMENT
  - A PATIENT WITH A MAJOR CARBOXYPEPTIDASE N DEFICIENCY BUT WITH NORMAL PROCARBOXYPEPTIDASE U (TAFI) SERUM LEVEL
  - PROCARBOXYPEPTIDASE U (TAFI) PLASMA LEVELS IN PATIENTS WITH HEREDITARY THROMBOPHILIA
  - PLASMA PROCPU (TAFI) AND CLOT LYSIS TIME ARE CORRELATED WITH CLOTTING FACTOR LEVELS AND THROMBIN GENERATION: A NOVEL APPROACH TO ASSESS THROMBOSIS RISK?
Williams J. - GENERATION OF INTERMEDIATE AFFINITY FORMS OF 2 I DOMAIN
Williams S. - COMPARISON OF SYSTEMIC TISSUE PLASMINOGEN ACTIVATOR FOR VENOUS THROMBI AND ARTERIAL THROMBI IN CHILDREN
  - THE EFFICACY AND SAFETY OF FRESH FROZEN PLASMA (FFP) AND SYSTEMIC TISSUE PLASMINOGEN ACTIVATOR FOR TREATMENT OF INTRAVASCULAR THROMBOSIS IN INFANTS
  - CLINICAL CHARACTERISTICS OF PULMONARY EMBOLISM IN CHILDHOOD- EXPERIENCE FROM A SINGLE CENTRE
  - TISSUE PLASMINOGEN ACTIVATOR AND PLASMINOGEN DOMAINS REGULATING THE POTENCY OF THERAPEUTIC THROMBOLYSIS
  - EVALUATION OF THROMBOLYTIC THERAPY WITH TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA) FOR PROSTHETIC VALVE THROMBOSIS IN CHILDREN: A SINGLE INSTITUTION EXPERIENCE
  - THE EFFICACY AND SAFETY OF ANTITHROMBIN CONCENTRATE IN CHILDREN RECEIVING HEPARIN INFUSIONS
Williams F.M.K. - PRELIMINARY RESULTS FROM EUROCLOT: HERITABILITY AND LINKAGE PEAKS FOR D-DIMER AND FIBRINOLYSIS TIME
Williams R.B. - PLATELET AGGREGATION AND SEROTONIN ACTIVITY
Williams J.A.E. - THE PLATELET ACTIVATION C-TYPE LECTIN RECEPTOR CLEC-2 SIGNALS VIA A NOVEL YXXL DEPENDENT SIGNALLING CASCADE DISTINCT FROM THAT OF ITAM RECEPTORS
Williams S. - THE SAFETY OF ANTICOAGULANTS IN PEDIATRIC ARTERIAL ISCHEMIC STROKE: PRELIMINARY RESULTS
Williams D. - CLINICAL EFFICACY OF ANTI-VENOM TREATMENT IN PAPUAN NEW GUINEA SNAKE-BITE PATIENTS
  - IN VITRO PLATELET AGGREGATION OF PAPUAN SNAKE VENOMS
  - ELTROMBOPAG, THE ORAL PLATELET GROWTH FACTOR, INCREASED PLATELET COUNT AND DID NOT AFFECT PLATELET FUNCTION WHEN ADMINISTERED TO HEALTHY MALE SUBJECTS
Williams H. - TISSUE TRANSGLUTAMINASE DOES NOT STABILIZE ARTERIAL PLAQUES IN THE APOE DEFICIENT MOUSE
Williams V.K. - THROMBOPHILIA IN PAEDIATRIC CYSTIC FIBROSIS PATIENTS
Williams S.A. - A NOVEL MUTATION IN EXON 10 OF FACTOR XIII SUBUNIT B
Williams S. - DIFFERENTIAL DOSING OF ENOXAPARIN (ENOX) IN TERM AND PRETERM NEONATES
  - DO WE NEED DIFFERENT STANDARD CURVES FOR MEASURING DIFFERENT LOW MOLECULAR WEIGHT HEPARINS?
Williams J. - EVALUATION OF THE POINT OF CARE MICRO-COAGULATION TESTS IN PEDIATRICS
Williams S. - OUTCOMES OF THROMBOLYSIS FOR REPEATED COURSES OF SYSTEMIC TISSUE PLASMINOGEN ACTIVATOR FOR INTRAVASCULAR THROMBOSIS IN CHILDREN
  - HEMORRHAGIC TRANSFORMATION OF ARTERIAL ISCHEMIC STROKE IN CHILDREN
Williams V.K. - COMPARISON OF COAGUCHEK S, XS AND LABORATORY INRS
Williams I.J. - HETEROGENEOUS SEQUENCE CHANGES IN THE PROMOTER AND CODING SEQUENCE OF THE FACTOR VIII GENE IDENTIFIED IN 247 FAMILIES FROM THE UK
Williams M.D. - HETEROGENEOUS SEQUENCE CHANGES IN THE PROMOTER AND CODING SEQUENCE OF THE FACTOR VIII GENE IDENTIFIED IN 247 FAMILIES FROM THE UK
Williams S. - THE ROLE OF FC-GAMMA RECEPTOR GENE POLYMORPHISMS IN THE CLINICAL OUTCOME OF NEWLY DIAGNOSED ITP IN CHILDREN
  - DOSING EFFICACY AND SAFETY OF UNFRACTIONATED HEPARIN IN INFANTS WITH THROMBOTIC COMPLICATIONS
Williamson D. - LOW-DOSE (1.2MG) RFVIIA TO REVERSE WARFARIN THERAPY IN CRITICALLY ILL PATIENTS WITH MAJOR BLEEDING
Williamson L.M. - RECOMBINANT HUMAN HPA-1A ANTIBODIES FOR TREATMENT OF FETO-MATERNAL ALLO-IMMUNE THROMBOCYTOPENIA (FMAIT): PROOF OF PRINCIPLE IN AN IN VIVO MURINE MODEL
Wilmer M. - EVALUATION OF A NEW FUNCTIONAL CLOTTING ASSAY FOR THE MONITORING OF HEPARIN AND HEPARINOID ANTICOAGULANTS BASED ON THROMBIN AND/OR FACTOR XA INHIBITION WITH CLINICAL PATIENT PLASMAS AT THREE UNIVERSITY MEDICAL CENTERS
Wilsgaard T. - FAMILY HISTORY OF MYOCARDIAL INFARCTION (MI) IS AN INDEPENDENT RISK FACTOR FOR VENOUS THROMBOEMBOLISM (VTE). THE TROMS STUDY
  - MEAN PLATELET VOLUME (MPV) IS AN INDEPENDENT RISK FACTOR FOR VENOUS THROMBOEMBOLISM (VTE). THE TROMS STUDY
Wilson K.M. - CRITICAL ROLE FOR CYCLOPHILIN D (CYPD) AND THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (MPTP) IN THE REGULATION OF PLATELET ACTIVATION AND THROMBOSIS
Wilson B. - IMPACTS OF GENETIC TESTING FOR THROMBOPHILIA ON FIRST DEGREE RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND A THROMBOPHILIA - A CROSS-SECTIONAL SURVEY
Wilson K.M. - REVERSAL OF HYPERCHOLESTEROLEMIA PROTECTS AGAINST ARTERIAL THROMBOSIS IN ATHEROSCLEROTIC MICE
Wilson B. - PSYCHOLOGICAL IMPACTS OF GENETIC TESTING FOR THROMBOPHILIA ON FIRST DEGREE RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND A THROMBOPHILIA A PILOT STUDY
Wiltshire T. - KLF4, A MODIFIER GENE IN GP6-NULL MICE
Wiman B. - A NEW SIMPLE AND RELIABLE METHOD FOR INVESTIGATING THE AFFINITY BETWEEN COLLAGEN AND VON WILLEBRAND FACTOR IN PLASMA SAMPLES
  - A NEW SIMPLE AND RELIABLE METHOD FOR INVESTIGATING THE AFFINITY BETWEEN FACTOR VIII AND VON WILLEBRAND FACTOR IN PLASMA SAMPLES
  - LABORATORY EVIDENCE OF HYPERFIBRINOLYSIS IN ASSOCIATION WITH LOW PAI-1 ACTIVITY
Winder A. - ANTI CD20 MONOCLONAL ANTIBODIES THERAPY FOR RESISTANT ANTIPHOSPHOLIPID SYNDROME
Windyga J. - CLINICAL EFFICACY AND SAFETY OF A NOVEL HIGH-PURITY, DOUBLE VIRUS-INACTIVATED VWF/FVIII-CONCENTRATE IN THE TREATMENT OF VON WILLEBRAND DISEASE AN UPDATE ON THE CLINICAL PROGRAMME
  - FINAL RESULTS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE PHARMACOKINETICS, EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15 NANOMETER-FILTERED PLASMA-DERIVED FACTOR VIII
  - "IMPACT R" - A NEW SCREENING TOOL FOR VON WILLEBRAND DISEASE?
  - THE EFFECT OF APCC AND PCC ON THE GENERATION OF THROMBIN IN HAEMOPHILIA A PATIENTS WITH FVIII INHIBITOR: A CROSS-OVER PHARMACOKINETIC STUDY
  - A PROSPECTIVE EFFICACY AND SAFETY STUDY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED FACTOR VIII ADMINISTERED BY CONTINUOUS INTRAVENOUS INFUSION IN SEVERE HAEMOPHILIA A PATIENTS UNDERGOING MAJOR SURGICAL PROCEDURES (PERFACT STUDY)
  - PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) 4G/4G GENOTYPE MAY INCREASE THE RISK OF THROMBOSIS IN SUBSET OF PATIENTS WITH PROTHROMBIN G20210A GENE MUTATION
  - BLOOD BORNE VIRUS INFECTIONS IN YOUNG HAEMOPHILIACS IN POLAND
  - WHAT DOES HIGH PREVALANCE OF FACTOR V LEIDEN MUTATION IN POLISH SEVERE HAEMOPHILIACS MEAN?
  - ABSENCE OF INHIBITOR FORMATION IN PREVIOUSLY TREATED HAEMOPHILIA A PATIENTS TREATED WITH A DOUBLE VIRUS INACTIVATED, PLASMA DERIVED FACTOR VIII/VWF CONCENTRATE IN PROSPECTIVE CLINICAL STUDIES
Winge S. - A NOVEL RECOMBINANT B-DOMAIN-DELETED FACTOR VIII EXPRESSED IN A HUMAN CELL LINE
Winkel K. - IN VITRO PLATELET AGGREGATION OF PAPUAN SNAKE VENOMS
  - CLINICAL EFFICACY OF ANTI-VENOM TREATMENT IN PAPUAN NEW GUINEA SNAKE-BITE PATIENTS
  - THE DIFFERENCES OF PLATELET RESPONSE TO SNAKE VENOMS: COMPARATIVE STUDY OF CHILDREN AND ADULTS
Winkelmann B.R. - LOW HDL CHOLESTEROL AND LOW HDL TRIGLCERIDES IN PATIENTS WITH SYMPTOMATIC AND ASYMPTOMATIC HIGH GRADE INTERNAL CAROTID ARTERY STENOSIS
  - THE Y2561 ALLELE OF A COMMON POLYMORPHISM IN THE C1 DOMAIN OF VON WILLEBRAND FACTOR APPEARS AS A NOVEL RISK FACTOR FOR MYOCARDIAL INFARCTION
Winkens M.H.M. - THROMBIN GENERATION AND COAGULATION MARKERS IN PATIENTS WITH A FIRST ACUTE MYOCARDIAL INFARCTION
  - THROMBOXANE B2 IN PATIENTS WITH A FIRST ACUTE MYOCARDIAL INFARCTION: THE INFLUENCE OF TREATMENT WITH ACETYLSALICYLIC ACID
Winkler C. - HFE GENE MUTATIONS DO NOT SHOW ASSOCIATIONS WITH HEMOPHILIC ARTHROPATHY
Winkler M. - AN EX VIVO PERFUSION MODEL TO STUDY THE TREATMENT OF THROMBOTIC MICROANGIOPATHY DURING PIG-TO-HUMAN XENOGENIC KIDNEY TRANSPLANTATION
Winn M.E. - AN ENU MUTAGENESIS SCREEN FOR DOMINANT GENETIC MODIFIERS OF THROMBOSIS IN THE FACTOR 5 LEIDEN MOUSE
Winning J. - BENEFICIAL EFFECTS OF ANTIPLATELET DRUGS IN SEPSIS: FIRST DATA FROM A CLINICAL AND ANIMAL STUDY
Winship P.R. - CHARACTERISATION OF PREDICTED OESTROGEN RESPONSE ELEMENTS IN THE ITGA2 GENE PROMOTER
  - DETERMINATION OF THE OESTROGEN RESPONSIVENESS OF A POLYMORPHIC ELEMENT IN THE HUMAN FACTOR IX GENE PROMOTER
  - FUNCTIONAL CHARACTERISATION OF HAPLOTYPIC VARIATION IN THE GP6 GENE PROMOTER
  - CHARACTERISATION OF ASE-LIKE ELEMENTS IN THE HUMAN PROTEIN Z GENE PROMOTER
Winter M. - HUMAN VASCULAR ENDOTHELIAL CELLS INFLUENCE THE WHOLE BLOOD THROMBIN GENERATION ASSAY
Winter P.C. - RECURRENCE OF THE FACTOR VIII GENE R531H MUTATION IN 13 IRISH FAMILIES: EVIDENCE FOR A FOUNDER EFFECT
Winter M. - WHOLE BLOOD AND PLASMA THROMBIN GENERATION ASSAYS IN PATIENTS WITH A HISTORY OF VENOUS THROMBOEMBOLISM
Winterhalter M. - AN EVALUATION OF SINGLE PORTION REAGENT VIALS FOR ROTEM ANALYSIS
Winters K.J. - EFFECT OF PRASUGREL AND HIGH DOSE CLOPIDOGREL ON PLATELET FUNCTION AS ASSESSED BY POINT OF CARE AND OPTICAL AGGREGOMETRY
  - GREATER PLATELET P2Y12 INHIBITION BY PRASUGREL COMPARED TO HIGH DOSE CLOPIDOGREL ASSESSED BY VASP PHOSPHORYLATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
Winters J. - RISK FACTORS FOR THROMBOTIC THROMBOCYTOPENIC PURPURA: RESULTS OF THE SURVEILLANCE, EPIDEMIOLOGY AND RISK FACTORS FOR TTP (SERF-TTP) GROUP
Winters K.J. - INDIVIDUAL AND COMBINED EFFECTS OF ASPIRIN AND THIENOPYRIDINES IN ATTENUATION OF PLATELET AGGREGATION INDUCED BY COLLAGEN AND OTHER AGONISTS
  - GREATER INHIBITION OF PLATELET ACTIVATION AND PLATELET-MONOCYTE COMPLEX FORMATION BY PRASUGREL COMPARED TO CLOPIDOGREL IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
Wire R. - HETEROCLITIN D, A COMPONENT OF PLANTS OF THE KADSURA SPECIES INHIBITS PAF-INDUCED PLATELET AGGREGATION, P-SELECTIN EXPRESSION AND PLATELET-LEUCOCYTE CONJUGATE FORMATION
Wirth M. - INCIDENCE AND DISEASE PATTERN OF VENOUS THROMBEMBOLISM AFTER RADICAL PROSTATECTOMY
Wise R. - INHIBITOR DEVELOPMENT IN SEVERE HEMOPHILIA A: IS THE RISK ASSOCIATED WITH PRODUCT TYPE?
Wissel T. - PRELIMINARY PERFORMANCE DATA OF A NEW QUANTITATIVE AND SENSITIVE D-DIMER ASSAY
Witke W. - COFILIN, BUT NOT ADF, IS ESSENTIAL IN PLATELET FORMATION IN VIVO
Witt D. - EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES
  - EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY
Wittevrongel C. - SEVERE GASTRO-INTESTINAL BLEEDING AND THROMBOCYTOPENIA DUE TO AN ANTI-GATA AUTOANTIBODY
  - HYPERREACTIVE PLATELETS IN PATIENTS WITH GS DEFICIENCY
Wittig I. - THROMBIN GENERATION IN PATIENTS WITH THROMBOPHILIA OR THROMBOSIS AND PREGNANCY
  - THROMBIN GENERATION AND THE TYPE OF ANTITHROMBIN DEFICIENCY
Wittig K. - THROMBIN GENERATION AND THE TYPE OF ANTITHROMBIN DEFICIENCY
Wittkowsky A.K. - THE RELATIVE EFFECTS OF VKORC1 AND CYP2C9 VARIANTS ON CLINICAL OUTCOMES IN WARFARIN PATIENTS
Wittkowsky A. - EFFICACY AND SAFETY OF WARFARIN MANAGEMENT IN US ANTICOAGULATION CLINICS
Wiviott S.D. - TISSUE FACTOR/FACTOR VIIA INHIBITOR REDUCES ISCHEMIA IN PATIENTS WITH NSTE-ACS: FINAL RESULTS OF THE ANTHEM-TIMI 32 TRIAL
Woehrer W. - BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF A RVWF DRUG CANDIDATE PRODUCED UNDER SERUM-FREE CONDITIONS
Woestenenk R. - ANTIPHOSPHOLIPID ANTIBODIES DISTURB 2D LATTICE FORMATION OF ANNEXINE A5 ON ACTIVATED PLATELETS
Wohner N. - STUDY OF THE STRUCTURAL DETERMINANTS OF ARTERIAL VESSEL WALL THROMBOGENICITY
Wojta J. - IN HUMAN MACROPHAGES THE COMPLEMENT COMPONENT C5A INDUCES THE EXPRESSION OF ONCOSTATIN M VIA AP-1 ACTIVATION
  - CORONARY INSTENT RESTENOSIS OF DRUG-ELUTING STENTS IS ASSOCIATED WITH SERUM LEVELS OF MMP-9
  - THROMBIN UPREGULATES EXPRESSION OF ONCOSTATIN M (OSM) IN HUMAN MACROPHAGES AND PERIPHERAL BLOOD MONOCYTES
  - ACTIVATED PROTEIN C INCREASES TISSUE FACTOR EXPRESSION ON HUMAN UMBILICAL ENDOTHELIAL CELL BY EPCR-DEPENDENT BUT PAR-1-INDEPENDENT MANNER
Wojtukiewicz M.Z. - EXPRESSION OF TISSUE FACTOR (TF), FACTOR X, PROTHROMBIN FRAGMENT 1+2 (F 1+2) AND FIBRIN IN BREAST CANCER: COMPARISON BETWEEN PRIMARY TUMOR AND METASTATIC LESIONS IN REGIONAL LYMPH NODES
Wolf H.H. - PLASMA CONCENTRATIONS OF TISSUE FACTOR AND COAGULATION FACTOR XIIA IN PREGNANT WOMEN
Wolf T. - INR RESULTS OF THE COAGUCHEK XS PLUS SYSTEM ARE EQUIVALENT TO THOSE OF THE COAGUCHEK XS SYSTEM
Wolf H.H. - THERAPY OF ACQUIRED HEMOPHILIA HAS CYTOTOXIC AND RITUXIMAB TREATMENT TO BE COMBINED WITH IMMUNOADSORPTION?
Wolf M. - ORGARAN CROSS REACTIVITY WITH HEPARIN INDUCED THROMBOCYTOPENIA ANTIBODIES: REPORT OF 12 CASES
Wolf T. - PERFORMANCE OF THE COAGUCHEK XS PLUS SYSTEM USING LIQUID QUALITY CONTROL SAMPLES
Wolf M. - TREATMENT OF VTE DURING PREGANCY WITH A ONCE-DAILY REGIMEN OF LMWH
Wolfs J.L. - HYPERGLYCEMIA ACCELERATES ARTERIAL THROMBUS FORMATION AND ATTENUATES THE ANTITHROMBOTIC RESPONSE TO ENDOTOXIN IN MICE
Wollersheim H. - COMPRESSION BANDAGING IN THE ACUTE PHASE OF DEEP-VEIN THROMBOSIS IN RELATION TO THE POST-THROMBOTIC SYNDROME
  - ELEVATED MARKERS OF INFLAMMATION IN THE ACUTE PHASE OF DEEP-VEIN THROMBOSIS ARE A RISK FACTOR FOR ELEVATED VENOUS RESISTANCE AS A PROXY OF THE POST-THROMBOTIC SYNDROME
Womack M. - FAILURE OF IMMUNE TOLERANCE INDUCTION IN HAEMOPHILIA B PATIENTS WITH C, T 6460 NONSENSE MUTATION
Wong D. - IS MEAN PLATELET VOLUME A USEFUL MARKER FOR THE 22Q11 DELETION
Wong J. - VENOUS THROMBOEMBOLISM AND CANCER: THE PERCEIVE REGISTRY
Wong W. - COST-EFFECTIVENESS (CE) OF ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE (APCC) VS. RECOMBINANT FVIIA IN PROPHYLAXIS IN HEMOPHILIA PATIENTS WITH INHIBITORS
Wong A. - ONCE DAILY TINZAPARIN SODIUM (175 INTERNATIONAL UNITS PER KG) IS SAFE AND EFFECTIVE FOR ANTENATAL THROMBOPROPHYLAXIS IN HIGH RISK PREGNANCIES AND FOR TREATMENT OF ANTENATAL VENOUS THROMBOEMBOLIC EVENTS
Wong W. - HEMOPHILIA PATIENTS WITH INHIBITORS UNDERGOING MAJOR ORTHOPEDIC SURGERIES: COST-MINIMIZATION ANALYSIS OF ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE (APCC) AND RECOMBINANT FVIIA
Wong P.C. - CLOPIDOGREL PRODUCES DISTINCT DOSE-RESPONSE RELATIONSHIPS FOR INHIBITION OF PLATELET AGGREGATION (IPA) AND ANTITHROMBOTIC EFFICACY MEASURED IN RATS AND RABBITS
  - POTENT ANTITHROMBOTIC ACTIVITY OF APIXABAN, A DIRECT FACTOR XA INHIBITOR, WITH MINIMUM BLEEDING TIME EFFECT IN RABBIT MODELS OF ARTERIAL THROMBOSIS AND HEMOSTASIS
Wong H.J. - LIVING DONOR LIVER TRANSPLANTATION FOR HBV-ASSOCIATED HEPATOMA IN A HEMOPHILIC PATIENT
Wongwerawattanakoon P. - NORMALIZED PHOSPHATIDYLSERINE EXPRESSION ON RED BLOOD CELLS IN CHILDREN WITH SEVERE THALASSEMIA DISEASE AFTER STEM CELL TRANSPLANTATION
  - THE USE OF RITUXIMAB AS AN ADJUVANT THERAPY TO INDUCE IMMUNE TOLERANCE IN CHILDREN WITH HEMOPHILIA A AND B
Woo Y.C. - PHARMACO-ECONOMIC EVALUATION OF TREATMENT ALTERNATIVES FOR MILD TO MODERATE BLEEDING EPISODES IN PATIENTS WITH HAEMOPHILIA WITH INHIBITORS IN KOREA
Woo K. - COMPARISON OF LABORATORY DETECTION METHODS OF ASPIRIN RESISTANCE IN CARDIOVASCULAR DISEASE PATIENTS
Woodhams B. - DECREASE FACTOR VIIA/ANTITHROMBIN COMPLEXES IN PATIENTS WITH VENOUS THROMBOEMBOLISM: A NEW INSIGHT IN THE PATHOGENETIC MECHANISM
  - ORAL ANTICOAGULATION SEVERELY IMPAIRS THE FUNCTION OF THE PROTEIN C SYSTEM
Woodhams B.J. - HIGH CONCENTRATION OF PROCOAGULANT PHOSPHOLIPIDS AND THROMBOMODULIN ACTIVITY ARE FOUND IN PREGNANCY COMPLICATIONS
  - HAEMOSTASIS DISTURBANCES IN TYPE I AND II DIABETES MELLITUS
  - NORMALISATION OF TGT RESULTS: IT MAY NOT BE AS EASY AS YOU THINK
  - A FUNCTIONAL AUTOMATED ASSAY FOR THROMBOMODULIN ACTIVITY IN PLASMA
Woodhams B. - DECREASE FACTOR VIIA/ANTITHROMBIN COMPLEXES IN 31 SUBJECTS BELONGING TO 7 FAMILIES WITH FVII DEFICIENCY
Woodhams B.J. - DETECTION OF HYPERCOAGULABILITY IN PATIENTS WITH THYROID CANCER
  - ASSAY DEVELOPMENT FOR PLASMA FACTOR VIIA-ANTITHROMBIN COMPLEX (FVIIA-AT)
  - THE EFFECT OF HIRUDIN ON THROMBIN GENERATION, APTT AND ECARIN CLOTTING TIME (ECT)
Woodhams B. - COMPARISON OF A HEPARIN-PLATELET FACTOR 4 (PF4)-ELISA FOR IGG, IGM AND IGA AND THE HEPARIN-INDUCED PLATELET ACTIVATION ASSAY (HIPA) WITH A HEPARIN-PF4-ELISA FOR IGG
Woodhams B.J. - USE OF SOLUBLE FIBRIN MONOMER (SFM) WITH DDIMER (DDI) AND THE ISTH SCORE MAY AID IN DIAGNOSIS OF DIC
  - FACTOR VIIA-ANTITHROMBIN COMPLEXES IN HUMAN PLASMA
Woods T.A.L. - VARIABILITY IN ANTICOAGULANT DOSING RECOMMENDATIONS; RESULTS FROM TWO UK NEQAS FOR BLOOD COAGULATION EXERCISES
Woods A. - THREE NEW POLYMORPHISMS LOCATED IN THE INTRON 2 OF THE ADAMTS13 GENE
Woods A.I. - BIOLOGICAL AND CLINICAL RESPONSE TO DESMOPRESSIN IN CHILDREN WITH VON WILLEBRAND DISEASE
Woods T.A.L. - AN EXTERNAL QUALITY ASSESSMENT PROGRAMME FOR PATIENT SELF-TESTING FOR MONITORING INRS- 2 YEARS OF RESULTS
Woods A. - THROMBIN STIMULATES AMP-ACTIVATED PROTEIN KINASE IN ENDOTHELIAL CELLS VIA A CAMKK-BETA-DEPENDENT PATHWAY
  - AN ASSOCIATION OF VICENZA AND NORMANDY VARIANTS VON WILLEBRAND DISEASE (VWD)
Woods T.A.L. - SOURCE AND USE OF REFERENCE RANGES IN HAEMOSTASIS: PRACTICE AMONGST UK NEQAS FOR BLOOD COAGULATION PARTICIPANTS 2005-6
Woods A. - VWF-CLEAVING SERINE PROTEASES ISOLATION DIFFERENT FROM ADAMTS13
Woods A.I. - IS THERE ANY CORRELATION BETWEEN FIBRINOLYTIC ACTIVITY AND BLEEDING SCORE IN TYPE 1 AND POSSIBLE TYPE 1 VON WILLEBRAND DISEASE?
Woods T.A. - DIFFERENCES IN THROMBOPHILIA ASSAY RESULTS BETWEEN COMMERCIAL REFERENCE PLASMAS USING THE SSC/ISTH SECONDARY COAGULATION STANDARD LOT#3 IN UK NEQAS FOR BLOOD COAGULATION PROFICIENCY TESTING EXERCISES
Woods A. - SYNDECAN-4 CONTRIBUTES TO ENDOTHELIAL TUBULOGENESIS THROUGH INTERACTIONS WITH TWO MOTIFS INSIDE THE PRO-ANGIOGENIC N-TERMINAL DOMAIN OF THROMBOSPONDIN-1
Woods T.A. - THE SSC/ISTH SECONDARY COAGULATION STANDARD LOT#3 IN UK NEQAS FOR BLOOD COAGULATION PROFICIENCY TESTING EXERCISES: MARKED DIFFERENCES IN FV AND FXI RESULTS BETWEEN COMMERCIAL REFERENCE PLASMAS
Woods T.A.L. - IMPLEMENTING AN EXTERNAL QUALITY ASSESSMENT PROGRAMME FOR USERS OF COAGUCHEK XS AND COAGUCHEK XS PLUS FOR MONITORING INRS
Woods Jr. V.L. - HETEROZYGOUS FIBRINOGEN GAMMA-114 TYR-HIS MUTATION ASSOCIATED WITH RESISTANCE TO TPA-MEDIATED FIBRINOLYSIS AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
  - HETEROZYGOUS FIBRINOGEN GAMMA-375 ARG-TRP MUTATION ASSOCIATED WITH EXCESSIVE SIALYLATION, PLASMIN RESISTANCE AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
Woodward M. - COMPARISON OF THE ASSOCIATIONS BETWEEN HAEMOSTATIC AND INFLAMMATORY VARIABLES AND CHD RISK: FLETCHER CHALLENGE STUDY
  - LOW ADAMTS13 LEVELS INCREASE THE RISK OF MYOCARDIAL INFARCTION (MI) INDEPENDENTLY OF VON WILLEBRAND FACTOR: GLASGOW MI STUDY
Woolery C. - OPTIMIZING CARE VIA INTERNET-BASED HEMOPHILIA THERAPY MANAGEMENT PLATFORM
Woollard K.J. - ENDOTHELIAL CELL TYPE AND ACTIVATION STATE AFFECTS SOLUBLE P-SELECTIN MEDIATED LEUKOCYTE ADHESION
  - FERRIC CHLORIDE INDUCES VASCULAR INJURY AND THROMBOSIS BY OXIDATIVE INJURY TO RED BLOOD CELLS
Woolley A. - IN VITRO ASSESSMENT OF ANTICOAGULATION REVERSAL WITH ROTEM THROMBOELASTOMETRY
  - ANTI XA ASSAYS FOR DANAPAROID: ASSESSMENT OF PRE ANALYTICAL AND ANALYTICAL VARIABLES
Wootla B. - IDENFICATION OF THE RECEPTORS IMPLICATED IN THE ENDOCYTOSIS OF FACTOR VIII BY HUMAN DENDRITIC CELLS
  - IGG ANTIBODIES WITH HYDROLYTIC ACTIVITY TOWARDS ENDOGENOUS FVIII IN A FRENCH COHORT OF PATIENTS WITH ACQUIRED HEMOPHILIA
  - KINETICS OF HYDROLYSIS BY FVIII HYDROLYZING ANTIBODIES IN ACQUIRED HEMOPHILIA A
Wright J.R. - PLATELETS INDUCE PAI-1 GENE EXPRESSION IN MONOCYTES THROUGH TGF-BETA
  - ACTIVATED PLATELETS INDUCE TISSUE FACTOR PATHWAY INHIBITOR IN PERIPHERAL BLOOD MONOCYTES
Wright A. - CIRCULATING PLATELET-MONOCYTE COMPLEXES AS POTENTIAL BIOMARKERS OF THE OVERALL ATHEROSCLEROSIS LOAD IN MEN WITH AND WITHOUT KNOWN CORONARY ARTERY DISEASE
Wright B. - STRUCTURE-FUNCTION RELATIONSHIPS OF POLYPHENOLS AND THE MODULATION OF PLATELET FUNCTION AND SIGNALLING
Wright M.D. - IMPAIRED 'OUTSIDE-IN' INTEGRIN ALPHAIIBBETA3 SIGNALING AND THROMBUS STABILITY IN CD151 AND TSSC6-DEFICIENT MICE
Wright J.R. - PAI-1 IN PLATELETS IS DEPENDENT ON THE 4G/5G POLYMORPHISM
Wu J. - IDENTIFICATION OF NOVEL PLATELET MEMBRANE PROTEINS USING MULTI-DIMENSIONAL PROTEIN IDENTIFICATION TECHNOLOGY
Wu H. - RECOMBINANT HUMAN THROMBOMODULIN PROMOTES SMOOTH MUSCLE CELL MIGRATION
  - DEXTROMETHORPHAN REDUCES ATHEROSCLEROSIS AND NEOINTIMA FORMATION IN MICE
Wu O. - THE INFLUENCE OF FACTOR V LEIDEN AND ABO(H) BLOOD GROUPS ON HAEMATOLOGY PARAMETERS IN EARLY PREGNANCY
Wu Y. - CLEAVED KININOGEN INHIBITS ANGIOGENESIS BY TARGETING ENDOTHELIAL CAVEOLAE
Wu X. - DOUBLE-DEFICIENCY OF RAC1 AND CDC42 SEVERELY AFFECTS PLATELET PRODUCTION AND FUNCTION
Wu J.S. - ACQUIRED FACTOR VIII INHIBITORS IN NON-HEMOPHILIC PATIENTS: CLINICAL EXPERIENCE OF 16 CASES
Wu J. - MOLECULAR CHARACTERIZATION OF A 4.4MBP DELETION OF THE HUMAN X CHROMOSOME IN A PATIENT WITH HAEMOPHILIA B
  - GENETIC DETERMINANTS OF NORMAL VARIATION IN ADAMTS-13 LEVELS: HERITABILITY ESTIMATE AND GENOME-WIDE SCAN
Wu X. - TRANSDUCTION OF COLONIC EPITHELIUM IN SEVERE HEMOPHILIA B BY NONINVASIVE APPROACH WITH RAAV2-HFIX RESULTED IN TRANSIENT EXPRESSION
Wu Y.P. - ROLE OF GLYCOPROTEIN IBA MOBILITY IN PLATELET DESTRUCTION AND FUNCTION
Wu J. - QUANTIFICATION OF ADAMTS13 ANTIGEN, ACTIVITY AND ADAMTS13/FXI COMPLEX FROM PATIENTS WITH HEMOSTATIC/THROMBOTIC DISORDERS
Wu J.R. - THROMBIN GENERATION PARAMETERS IN A PLATELET-POOR PLASMA MODEL SYSTEM AND THEIR USE IN PATIENTS WITH SINGLE FACTOR DEFICIENCY
Wu H. - KNOCKOUT OF THE THROMBOXANE SYNTHASE CAUSES REDUCTION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND MIGRATION IN AN ARTERY INJURY MODEL
Wu J. - THE TIGHT JUNCTION PROTEIN ESAM IS RECRUITED TO PLATELET-PLATELET CONTACTS AND FORMS SIGNALING COMPLEXES THAT AFFECT THROMBUS GROWTH AND STABILITY
  - THE CANADIAN RARE INHERITED BLEEDING DISORDERS REGISTRY (RIBDR) OF COAGULATION FACTOR DEFICIENCIES AND PLATELET FUNCTION DISORDERS
Wu Y.F. - SUPERWARFARIN INTOXIFICATION: HEMATURIA IS A MAJOR CLINICAL MANIFESTATION
Wu Y. - THE OUTER-SURFACES OF SCHISTOSOMA MANSONI DURING THE LIFE-CYCLE DEMONSTRATE DIFFERENTIAL PROPERTIES TOWARDS PLATELET ADHESION
Wu S. - ESTABLISHMENT OF A FLOW CYTOMETRIC ASSAY FOR QUANTITATIVE DETECTION OF HUMAN PLATLET GLYCOPROTEIN VI BY A MOUSE POLYCLONAL ANTIBODY
Wu J. - DIFFERENTIAL DOSING OF ENOXAPARIN (ENOX) IN TERM AND PRETERM NEONATES
Wu H. - THE REGULATION OF THROMBOMODULIN DISTRIBUTION IN ENDOTHELIAL CELLS
Wu H.M. - A NEW ADAMTS13 ACTIVITY ASSAY USED WITH ANTIGEN ASSAY PROVIDES DIAGNOSTIC INFORMATION IN TTP, BLEEDING OR THROMBOSIS
Wu S. - LACK OF ASSOCIATION OF ANTIPHOSPHOLIPID ANTIBODIES WITH CORONARY ATHEROSCLEROSIS IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
Wu O. - THE GOAL STUDY: A PROSPECTIVE EXAMINATION OF THE IMPACT OF FACTOR V LEIDEN AND ABO (H) BLOOD GROUPS ON HAEMORRHAGIC AND THROMBOTIC PREGNANCY OUTCOMES
Wu C. - THE INFLUENCE OF THE HEMODIALYSIS PROCEDURES ON PLATELET AND HEMOSTATIC FUNCTIONS
Wu Y.F. - NOVEL MUTATIONS IN THE FACTOR V GENE OF TAIWANESE FACTOR V DEFICIENCY PATIENTS
Wu J. - A NOVEL DELETION MUTATION (C.1254 DEL33BP OR C.1251DEL33BP) IN THE F13A GENE CAUSING SEVERE FACTOR XIII DEFICIENCY
Wu H.L. - ELEVATED PLASMA FREE FATTY ACID LEVEL (MYRISTIC ACID, PALMITIC ACID, STEARIC ACID) IN TYPE 2 DIABETIC INDIVIDUAL
Wu J. - HEREDITARY COAGULATION FACTOR XIII DEFICIENCY CAUSED BY A DELETION MUTATION OF F13A GENE
Wu C.M. - A SYSTEMATIC REVIEW OF THE INCIDENCE OF VENOUS THROMBOEMBOLISM (VTE) AND EFFECTIVENESS OF PROPHYLAXIS IN PATIENTS WITH MULTIPLE MYELOMA (MM) RECEIVING THALIDOMIDE
Wu D. - ALTERATIONS OF HEMOSTATIC PARAMETERS IN PATIENTS RECEIVING HEMATOPOIETIC STEM CELL TRANSPLANTATION
Wu Wen S. - FACTOR V LEIDEN (FVL) AND PROTHROMBIN GENE VARIANT (PGV) MAY BE ONLY WEAKLY ASSOCIATED WITH PLACENTA MEDIATED PREGNANCY COMPLICATIONS: A LARGE PROSPECTIVE COHORT STUDY
Wuillemin W.A. - PHARMACOKINETICS OF DALTEPARIN IN PROPHYLACTIC DOSAGE IN PATIENTS WITH IMPAIRED RENAL FUNCTION
  - VON WILLEBRAND FACTOR RELATED PARAMETERS IN SEVERE SEPSIS AND SEPTIC SHOCK
Wun T. - EXPLORING ADULT PATIENT POPULATIONS AT RISK FOR DEVELOPING HIT
  - CAUSE OF DEATH AMONG PATIENTS WITH LOCAL OR REGIONAL STAGE CANCER OF THE BREAST AND LUNG WHO DEVELOP VENOUS THROMBOEMBOLISM (VTE)
  - VENOUS THROMBOEMBOLISM IN ACUTE LEUKEMIA PATIENTS: INCIDENCE, RISK FACTORS, AND MORTALITY
Wurtz V. - IDENTIFICATION OF PF4 AND BETA-TG BY PROFILING AND LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY OF SUPERNATANT PEPTIDES IN STORED APHERESIS AND BUFFY-COAT PLATELET CONCENTRATES
Wurzinger L.J. - FIBRIN-MEDIATED THROMBUS FIXATION TO ENDOTHELIUM LEADS TO MONOLAYER DISRUPTION AFTER SHEAR INDUCED THROMBUS DISLODGEMENT
Wygrecka M. - FACTOR VII ACTIVATING PROTEASE (FSAP)
  - INHIBITION OF PLATELET-DERIVED GROWTH FACTOR-BB (PDGF-BB) FUNCTION BY FACTOR VII ACTIVATING PROTEASE (FSAP): ROLE OF PROTEASE NEXIN-1 (PN-1) AND LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP)
Wynn R. - AN AUDIT OF THROMBOPHILIA SCREENING IN A SINGLE PAEDIATRIC TERTIARY REFERRAL CENTRE
Wynne K. - PROTEOMIC ANALYSIS OF PLATELET DETERGENT-RESISTANT MEMBRANES FROM HEALTHY HUMAN DONORS WITH "EXTREME-END" RESPONSES TO COLLAGEN-RELATED PEPTIDE AND ADP
  - PROTEOMIC ANALYSIS OF THE SHP-1 INTERACTOME IN HUMAN PLATELETS
| ISTH 2009